
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Synthesis and biological activity study of tanshinone I-pyridinium salt derivatives - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE48C689B741F31B48C6003A7158D6.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="natprobio">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332164/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Natural Products and Bioprospecting">
<meta name="citation_title" content="Synthesis and biological activity study of tanshinone I-pyridinium salt derivatives">
<meta name="citation_author" content="Huimin Zhao">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Yuyang Wang">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Zining Liu">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Lin Lin">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Jiasi Xiang">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Zihao Zhu">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Xiongli Yang">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Yongsheng Fang">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Lingmei Kong">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_author" content="Yan Li">
<meta name="citation_author_institution" content="Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="15">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="51">
<meta name="citation_doi" content="10.1007/s13659-025-00534-7">
<meta name="citation_pmid" content="40775593">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332164/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332164/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332164/pdf/13659_2025_Article_534.pdf">
<meta name="description" content="Natural product tanshinone I exhibits weak potency and poor drug-like properties, which have restricted its clinical development as an anticancer agent. Herein, twenty novel tanshinone I-pyridinium salt derivatives and a pyridinium salt precursor ...">
<meta name="og:title" content="Synthesis and biological activity study of tanshinone I-pyridinium salt derivatives">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Natural product tanshinone I exhibits weak potency and poor drug-like properties, which have restricted its clinical development as an anticancer agent. Herein, twenty novel tanshinone I-pyridinium salt derivatives and a pyridinium salt precursor ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332164/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12332164">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s13659-025-00534-7"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13659_2025_Article_534.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332164%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12332164/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12332164/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332164/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-natprobio.gif" alt="Natural Products and Bioprospecting logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Natural Products and Bioprospecting" title="Link to Natural Products and Bioprospecting" shape="default" href="http://link.springer.com/journal/13659" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Nat Prod Bioprospect</button></div>. 2025 Aug 8;15(1):51. doi: <a href="https://doi.org/10.1007/s13659-025-00534-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s13659-025-00534-7</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Nat%20Prod%20Bioprospect%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nat%20Prod%20Bioprospect%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Nat%20Prod%20Bioprospect%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Nat%20Prod%20Bioprospect%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Synthesis and biological activity study of tanshinone I-pyridinium salt derivatives</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Huimin Zhao</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Huimin Zhao</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Huimin Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yuyang Wang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yuyang Wang</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuyang Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Zining Liu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Zining Liu</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zining Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Lin Lin</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Lin Lin</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lin Lin</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jiasi Xiang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jiasi Xiang</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiasi Xiang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Zihao Zhu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Zihao Zhu</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zihao Zhu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Xiongli Yang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Xiongli Yang</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiongli Yang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Yongsheng Fang</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Yongsheng Fang</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yongsheng Fang</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kong%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Lingmei Kong</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Lingmei Kong</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kong%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lingmei Kong</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Yan Li</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Yan Li</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan Li</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500 People’s Republic of China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 6; Accepted 2025 Jul 24; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12332164  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40775593/" class="usa-link">40775593</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Natural product tanshinone I exhibits weak potency and poor drug-like properties, which have restricted its clinical development as an anticancer agent. Herein, twenty novel tanshinone I-pyridinium salt derivatives and a pyridinium salt precursor were designed and synthesized, and their antitumor activities were evaluated. Among these tanshinone I-pyridinium salts, compound <strong>a4</strong>, bearing a 4-bromobenzoylmethyl substituent at the <em>N</em>-1 position of the pyridine ring, showed the most potent cytotoxicity against breast cancer (MDA-MB-231), hepatocellular carcinoma (HepG2), and prostate cancer (22RV1) cell lines, with IC<sub>50</sub> values of 1.40–1.63 μM. Preliminary mechanistic studies suggest that <strong>a4</strong> targets PI3Kα with the IC<sub>50</sub> of 9.24 ± 0.20 μM and exerts effective inhibition of the phosphorylation of key PI3K/Akt/mTOR signaling proteins. Besides, <strong>a4</strong> significantly downregulates the expression of the immune checkpoint protein PD-L1, indicating its potential to activate tumor immunity. These findings demonstrate that tanshinone I-pyridinium salt derivative <strong>a4</strong> is a novel PI3Kα inhibitor, providing a solid foundation for further development of antitumor agents.</p>
<section id="sec1"><h3 class="pmc_sec_title">Graphical Abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/a7614f60f196/13659_2025_534_Figa_HTML.jpg" loading="lazy" id="MO1" height="393" width="785" alt="graphic file with name 13659_2025_534_Figa_HTML.jpg"></a></p></section><section id="sec2"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1007/s13659-025-00534-7.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Tanshinone I, Pyridinium salts, Structural modification, Antitumor activity, Structure–activity relationship</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">Cancer is a complex genomic disorder characterized by significant heterogeneity and drug resistance, greatly complicating its treatment [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Although current therapeutic strategies, including chemotherapy, targeted therapy, and immunotherapy, have improved patient survival to some extent, their clinical effectiveness remains limited by poor selectivity, significant toxicity, and acquired drug resistance [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Thus, developing novel anticancer agents with high selectivity and low toxicity remains in great demand for current medicinal chemistry research [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>].</p>
<p id="Par4">Natural products, particularly those derived from traditional Chinese medicines, have long served as valuable sources for anticancer drug discovery due to their structural diversity and multi-targeted effects [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. <em>Salvia miltiorrhiza</em>, a widely-used traditional Chinese medicinal herb for cardiovascular diseases, contains bioactive constituents known as tanshinones that have exhibited potential anticancer activity [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Tanshinones, such as tanshinone I (Tan I), tanshinone IIA (Tan IIA), dihydrotanshinone (DHT) and cryptotanshinone (CPT), exhibit multiple anticancer mechanisms, including anti-proliferative effects, apoptosis induction, immune modulation, and angiogenesis inhibition [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>] (Fig. <a href="#Fig1" class="usa-link">1</a>A). Among these, tanshinone I (T1), despite its relatively low abundance and limited research, has demonstrated prominent inhibitory effects against various cancers, including breast, liver, and prostate cancer [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. However, the clinical application of tanshinone I has been restricted by its low aqueous solubility, poor bioavailability, and unfavorable pharmacokinetic properties [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/2cc8c9722fa8/13659_2025_534_Fig1_HTML.jpg" loading="lazy" id="MO2" height="960" width="776" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Tanshinone molecular heterozygous design of tanshinone I. <strong>A</strong> Representative tanshinones extracted from <em>Salvia miltiorrhiza</em>. <strong>B</strong> Molecular heterozygous design of the natural product tanshinone I with pyridinium salt for drug discovery</p></figcaption></figure><p id="Par5">To enhance its solubility, bioavailability, anticancer activity, and selectivity, structural modification of tanshinone through molecular hybridization by incorporating pharmacophores such as pyridinium salt has been performed in the study [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>–<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Pyridine moieties are widely present in numerous FDA-approved anticancer drugs due to their favorable electronic properties and hydrogen bond acceptor capabilities, which can enhance pharmacokinetic profiles and molecular interactions [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>–<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. It has been reported that over 20% of small-molecule anticancer agents contain a pyridine ring or its derivatives. Representative examples include Sorafenib, Vismodegib, and Crizotinib (Fig. <a href="#Fig1" class="usa-link">1</a>B). Based on this rationale, we introduced an imidazole linker into ring C of Tan I and synthesized a series of novel tanshinone I-pyridinium salt derivatives, whose anticancer activities and preliminary mechanisms were systematically investigated [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. This study not only expands structural diversity and biological applications of tanshinone derivatives but also provides new directions for the development of novel anticancer agents.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results and discussion</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Chemistry</h3>
<p id="Par6">As shown in Scheme <a href="#Sch1" class="usa-link">1</a>, tanshinone I (<strong>a1</strong>) is structurally characterized by a naphthalene ring A/B, an ortho-quinone ring C, and a furan ring D. To enhance aqueous solubility and molecular stability, structural modification of tanshinone I was performed by introducing an imidazole moiety as a linker onto ring C and a pyridine ring to form the salt, using commercially available tanshinone I (<strong>a1</strong>) as the starting material. Specifically, pyridine derivative <strong>a2</strong> was synthesized via the Debus-Radziszewski reaction of <strong>a1</strong> with 3-pyridinecarboxaldehyde in acetic acid and ammonium acetate under microwave irradiation (100 °C). Single crystals of compound <strong>a2</strong> were obtained by solvent crystallization, and the structure of <strong>a2</strong> was confirmed by single-crystal X-ray diffraction analysis (CCDC 2447458, Fig. <a href="#Fig2" class="usa-link">2</a>). Subsequent quaternization of pyridine derivative <strong>a2</strong> with various alkyl bromides in acetonitrile afforded a series of tanshinone I-pyridinium salts (<strong>a3-a22</strong>) in yields ranging from 36 to 97%. To summarize, the structures and yields of all new tanshinone I-pyridinium salts derivatives were shown in Table <a href="#Tab1" class="usa-link">1</a>.</p>
<figure class="fig xbox font-sm" id="Sch1"><h4 class="obj_head">Scheme 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Sch1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/8ed00bf0869c/13659_2025_534_Sch1_HTML.jpg" loading="lazy" id="MO3" height="227" width="785" alt="Scheme 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Sch1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Synthesis of tanshinone I-pyridinium salts Derivatives <strong>a3-a22</strong></p></figcaption></figure><figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/7ea98cff0cc1/13659_2025_534_Fig2_HTML.jpg" loading="lazy" id="MO4" height="648" width="797" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>X-ray crystal structure of compound<strong> a2</strong></p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Structures and yields of tanshinone I-pyridinium salts Derivatives <strong>a3-a22</strong></p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">No</th>
<th align="left" colspan="1" rowspan="1">Compounds</th>
<th align="left" colspan="1" rowspan="1">R</th>
<th align="left" colspan="1" rowspan="1">Molecular Formula</th>
<th align="left" colspan="1" rowspan="1">Yields</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1"><strong>a3</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/23b6642c99da/13659_2025_534_Figb_HTML.gif" loading="lazy" id="d33e431" height="302" width="417" alt="graphic file with name 13659_2025_534_Figb_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>32</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>2</sub>
</td>
<td align="left" colspan="1" rowspan="1">85%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1"><strong>a4</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/e3fc5e7817f3/13659_2025_534_Figc_HTML.gif" loading="lazy" id="d33e454" height="79" width="131" alt="graphic file with name 13659_2025_534_Figc_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>31</sub>H<sub>23</sub>Br<sub>2</sub>N<sub>3</sub>O<sub>2</sub>
</td>
<td align="left" colspan="1" rowspan="1">76%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1"><strong>a5</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/ec238ff8bcd3/13659_2025_534_Figd_HTML.gif" loading="lazy" id="d33e479" height="79" width="144" alt="graphic file with name 13659_2025_534_Figd_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>33</sub>H<sub>26</sub>BrN<sub>3</sub>O<sub>3</sub>
</td>
<td align="left" colspan="1" rowspan="1">90%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1"><strong>a6</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/503071bf6868/13659_2025_534_Fige_HTML.gif" loading="lazy" id="d33e502" height="80" width="144" alt="graphic file with name 13659_2025_534_Fige_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>36</sub>H<sub>26</sub>BrN<sub>3</sub>O<sub>2</sub>
</td>
<td align="left" colspan="1" rowspan="1">36%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1"><strong>a7</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/7c41b7d34d39/13659_2025_534_Figf_HTML.gif" loading="lazy" id="d33e525" height="205" width="420" alt="graphic file with name 13659_2025_534_Figf_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>32</sub>H<sub>26</sub>BrN<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">67%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1"><strong>a8</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/1574b73b4eaf/13659_2025_534_Figg_HTML.gif" loading="lazy" id="d33e547" height="253" width="354" alt="graphic file with name 13659_2025_534_Figg_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>32</sub>H<sub>23</sub>BrN<sub>4</sub>O</td>
<td align="left" colspan="1" rowspan="1">84%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1"><strong>a9</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/5042ecce1df5/13659_2025_534_Figh_HTML.gif" loading="lazy" id="d33e569" height="200" width="317" alt="graphic file with name 13659_2025_534_Figh_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>31</sub>H<sub>26</sub>Br<sub>2</sub>N<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">69%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1"><strong>a10</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/b25a324b024c/13659_2025_534_Figi_HTML.gif" loading="lazy" id="d33e593" height="201" width="460" alt="graphic file with name 13659_2025_534_Figi_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>31</sub>H<sub>23</sub>Br<sub>2</sub>N<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">89%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1"><strong>a11</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/07423da559ad/13659_2025_534_Figj_HTML.gif" loading="lazy" id="d33e617" height="201" width="462" alt="graphic file with name 13659_2025_534_Figj_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>31</sub>H<sub>23</sub>BrClN<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">92%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1"><strong>a12</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/8b0a42741c60/13659_2025_534_Figk_HTML.gif" loading="lazy" id="d33e639" height="200" width="413" alt="graphic file with name 13659_2025_534_Figk_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>31</sub>H<sub>23</sub>BrFN<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">97%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1"><strong>a13</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/cdb5ce4beaaa/13659_2025_534_Figl_HTML.gif" loading="lazy" id="d33e661" height="78" width="129" alt="graphic file with name 13659_2025_534_Figl_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>32</sub>H<sub>23</sub>BrF<sub>3</sub>N<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">85%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1"><strong>a14</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/c0e1ef74d632/13659_2025_534_Figm_HTML.gif" loading="lazy" id="d33e686" height="65" width="200" alt="graphic file with name 13659_2025_534_Figm_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>32</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>2</sub>
</td>
<td align="left" colspan="1" rowspan="1">74%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="left" colspan="1" rowspan="1"><strong>a15</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/e7481bd65a2f/13659_2025_534_Fign_HTML.gif" loading="lazy" id="d33e709" height="204" width="419" alt="graphic file with name 13659_2025_534_Fign_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>32</sub>H<sub>26</sub>BrN<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">60%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">14</td>
<td align="left" colspan="1" rowspan="1"><strong>a16</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/df82179f3ba0/13659_2025_534_Figo_HTML.gif" loading="lazy" id="d33e731" height="204" width="462" alt="graphic file with name 13659_2025_534_Figo_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>31</sub>H<sub>22</sub>BrCl<sub>2</sub>N<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">79%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1"><strong>a17</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/d18e0d2e2cd3/13659_2025_534_Figp_HTML.gif" loading="lazy" id="d33e755" height="79" width="195" alt="graphic file with name 13659_2025_534_Figp_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>31</sub>H<sub>22</sub>BrFN<sub>4</sub>O<sub>3</sub>
</td>
<td align="left" colspan="1" rowspan="1">61%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">16</td>
<td align="left" colspan="1" rowspan="1"><strong>a18</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/cde14b6cca96/13659_2025_534_Figq_HTML.gif" loading="lazy" id="d33e778" height="78" width="195" alt="graphic file with name 13659_2025_534_Figq_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>32</sub>H<sub>25</sub>BrN<sub>4</sub>O<sub>3</sub>
</td>
<td align="left" colspan="1" rowspan="1">47%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="left" colspan="1" rowspan="1"><strong>a19</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/db22b2140706/13659_2025_534_Figr_HTML.gif" loading="lazy" id="d33e801" height="78" width="195" alt="graphic file with name 13659_2025_534_Figr_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>31</sub>H<sub>22</sub>Br<sub>2</sub>N<sub>4</sub>O<sub>3</sub>
</td>
<td align="left" colspan="1" rowspan="1">40%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1"><strong>a20</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/dae1382a6b1d/13659_2025_534_Figs_HTML.gif" loading="lazy" id="d33e826" height="368" width="312" alt="graphic file with name 13659_2025_534_Figs_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>35</sub>H<sub>26</sub>BrN<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">87%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1"><strong>a21</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/c5a5490c5453/13659_2025_534_Figt_HTML.gif" loading="lazy" id="d33e848" height="207" width="465" alt="graphic file with name 13659_2025_534_Figt_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>35</sub>H<sub>26</sub>BrN<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">65%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="left" colspan="1" rowspan="1"><strong>a22</strong></td>
<td align="left" colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/2a085da70881/13659_2025_534_Figu_HTML.gif" loading="lazy" id="d33e870" height="162" width="265" alt="graphic file with name 13659_2025_534_Figu_HTML.gif"></td>
<td align="left" colspan="1" rowspan="1">C<sub>28</sub>H<sub>24</sub>BrN<sub>3</sub>O</td>
<td align="left" colspan="1" rowspan="1">73%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec4"><h3 class="pmc_sec_title">Biological evaluation and structure–activity relationship analysis</h3>
<section id="Sec5"><h4 class="pmc_sec_title">Biological assay procedures and results</h4>
<p id="Par7">Twenty synthesized tanshinone I-pyridinium salt derivatives (<strong>a3-a22</strong>), together with tanshinone I (<strong>a1</strong>) and pyridine derivative (<strong>a2</strong>), were evaluated in vitro for their cytotoxic activity against three human cancer cell lines, including breast cancer (MDA-MB-231), hepatocellular carcinoma (HepG2), and prostate cancer (22RV1), by using the MTS assay. Cisplatin (DDP) and paclitaxel were chosen as positive controls. The results are summarized in Table <a href="#Tab2" class="usa-link">2</a>.</p>
<section class="tw xbox font-sm" id="Tab2"><h5 class="obj_head">Table 2.</h5>
<div class="caption p"><p>Cytotoxic activities of tanshinone I-pyridinium salts Derivatives <strong>a3</strong>-<strong>a22</strong> in <em>vitro</em><sup>b</sup> (IC<sub>50</sub>, µM<sup>a</sup>)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr><th align="left" colspan="5" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/14e7282611fb/13659_2025_534_Figv_HTML.gif" loading="lazy" id="d33e931" height="152" width="100" alt="graphic file with name 13659_2025_534_Figv_HTML.gif"></th></tr>
<tr>
<th align="left" rowspan="2" colspan="1">No</th>
<th align="left" rowspan="2" colspan="1">Compounds</th>
<th align="left" colspan="3" rowspan="1">IC<sub>50</sub> (μM)</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1"><strong>MDA-MB-231</strong></th>
<th align="left" colspan="1" rowspan="1"><strong>HepG2</strong></th>
<th align="left" colspan="1" rowspan="1"><strong>22RV1</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>1</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a1</strong></td>
<td align="left" colspan="1" rowspan="1">7.17 ± 0.14</td>
<td align="left" colspan="1" rowspan="1">6.34 ± 0.02</td>
<td align="left" colspan="1" rowspan="1">10.61 ± 2.49</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>2</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a2</strong></td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>3</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a3</strong></td>
<td align="left" colspan="1" rowspan="1">1.06 ± 0.12</td>
<td align="left" colspan="1" rowspan="1">1.30 ± 0.06</td>
<td align="left" colspan="1" rowspan="1">2.19 ± 0.44</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>4</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a4</strong></td>
<td align="left" colspan="1" rowspan="1">1.41 ± 0.04</td>
<td align="left" colspan="1" rowspan="1">1.63 ± 0.04</td>
<td align="left" colspan="1" rowspan="1">1.40 ± 0.66</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>5</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a5</strong></td>
<td align="left" colspan="1" rowspan="1">1.19 ± 0.12</td>
<td align="left" colspan="1" rowspan="1">1.21 ± 0.01</td>
<td align="left" colspan="1" rowspan="1">2.82 ± 0.34</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>6</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a6</strong></td>
<td align="left" colspan="1" rowspan="1">4.13 ± 0.12</td>
<td align="left" colspan="1" rowspan="1">6.87 ± 0.85</td>
<td align="left" colspan="1" rowspan="1">13.91 ± 2.13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>7</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a7</strong></td>
<td align="left" colspan="1" rowspan="1">1.35 ± 0.07</td>
<td align="left" colspan="1" rowspan="1">2.08 ± 0.01</td>
<td align="left" colspan="1" rowspan="1">1.62 ± 0.02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>8</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a8</strong></td>
<td align="left" colspan="1" rowspan="1">4.10 ± 0.08</td>
<td align="left" colspan="1" rowspan="1">8.72 ± 0.14</td>
<td align="left" colspan="1" rowspan="1">11.62 ± 3.61</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>9</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a9</strong></td>
<td align="left" colspan="1" rowspan="1">5.56 ± 0.33</td>
<td align="left" colspan="1" rowspan="1">7.08 ± 0.20</td>
<td align="left" colspan="1" rowspan="1">5.84 ± 1.18</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>10</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a10</strong></td>
<td align="left" colspan="1" rowspan="1">2.32 ± 0.09</td>
<td align="left" colspan="1" rowspan="1">7.62 ± 0.24</td>
<td align="left" colspan="1" rowspan="1">10.14 ± 0.23</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>11</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a11</strong></td>
<td align="left" colspan="1" rowspan="1">2.01 ± 0.28</td>
<td align="left" colspan="1" rowspan="1">5.35 ± 0.32</td>
<td align="left" colspan="1" rowspan="1">6.97 ± 1.42</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>12</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a12</strong></td>
<td align="left" colspan="1" rowspan="1">4.08 ± 1.15</td>
<td align="left" colspan="1" rowspan="1">7.38 ± 1.38</td>
<td align="left" colspan="1" rowspan="1">12.51 ± 3.09</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>13</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a13</strong></td>
<td align="left" colspan="1" rowspan="1">4.21 ± 0.06</td>
<td align="left" colspan="1" rowspan="1">7.86 ± 0.52</td>
<td align="left" colspan="1" rowspan="1">9.05 ± 2.66</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>14</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a14</strong></td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>15</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a15</strong></td>
<td align="left" colspan="1" rowspan="1">4.68 ± 0.61</td>
<td align="left" colspan="1" rowspan="1">5.48 ± 0.75</td>
<td align="left" colspan="1" rowspan="1">11.07 ± 3.26</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>16</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a16</strong></td>
<td align="left" colspan="1" rowspan="1">7.11 ± 0.49</td>
<td align="left" colspan="1" rowspan="1">9.06 ± 1.42</td>
<td align="left" colspan="1" rowspan="1">14.86 ± 1.88</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>17</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a17</strong></td>
<td align="left" colspan="1" rowspan="1">4.95 ± 0.15</td>
<td align="left" colspan="1" rowspan="1">7.19 ± 0.32</td>
<td align="left" colspan="1" rowspan="1">11.17 ± 1.46</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>18</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a18</strong></td>
<td align="left" colspan="1" rowspan="1">6.44 ± 0.41</td>
<td align="left" colspan="1" rowspan="1">9.78 ± 1.04</td>
<td align="left" colspan="1" rowspan="1">12.86 ± 0.73</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>19</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a19</strong></td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
<td align="left" colspan="1" rowspan="1"> &gt; 20</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>20</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a20</strong></td>
<td align="left" colspan="1" rowspan="1">1.70 ± 0.09</td>
<td align="left" colspan="1" rowspan="1">2.39 ± 0.15</td>
<td align="left" colspan="1" rowspan="1">2.76 ± 1.10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>21</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a21</strong></td>
<td align="left" colspan="1" rowspan="1">5.41 ± 0.08</td>
<td align="left" colspan="1" rowspan="1">5.50 ± 1.01</td>
<td align="left" colspan="1" rowspan="1">11.66 ± 0.28</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>22</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>a22</strong></td>
<td align="left" colspan="1" rowspan="1">5.66 ± 0.21</td>
<td align="left" colspan="1" rowspan="1">8.05 ± 0.29</td>
<td align="left" colspan="1" rowspan="1">6.77 ± 1.37</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>23</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>DDP</strong></td>
<td align="left" colspan="1" rowspan="1">3.47 ± 0.41</td>
<td align="left" colspan="1" rowspan="1">4.60 ± 0.14</td>
<td align="left" colspan="1" rowspan="1">5.10 ± 0.14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>24</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>Taxol</strong></td>
<td align="left" colspan="1" rowspan="1"> &lt; 0.008</td>
<td align="left" colspan="1" rowspan="1"> &lt; 0.008</td>
<td align="left" colspan="1" rowspan="1"> &lt; 0.008</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p14">
<p><sup>a</sup> Cytotoxicity as IC<sub>50</sub> for each cell line, is the concentration of compound which reduced by 50% the optical density of treated cells with respect to untreated cells using the MTS assay</p>
<p><sup>b</sup> Data represent the mean values of three independent determinations</p>
</div></div></section></section><section id="Sec6"><h4 class="pmc_sec_title">Aqueous solubility analysis</h4>
<p id="Par8">The aqueous solubility of selected analogues exhibiting enhanced antitumor activity (<strong>a2</strong>, <strong>a4</strong>, and <strong>a16</strong>) was evaluated by a previously reported ultraviolet–visible (UV–Vis) spectrophotometric method [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. As anticipated, the conversion of these derivatives into their corresponding pyridinium salts significantly improved their aqueous solubility compared to the parent compound <strong>a1</strong>. Specifically, the pyridinium salts <strong>a4</strong> and <strong>a16</strong> demonstrated notably higher solubilities (85 ± 4 μg/mL and 86 ± 5 μg/mL, respectively) relative to their non-salt precursor <strong>a2</strong> (32 ± 5 μg/mL). These findings highlight the beneficial impact of pyridinium salt formation on enhancing the aqueous solubility of the synthesized compounds. By comparison, the aqueous solubility of compound <strong>a1</strong> was too low to be accurately determined by this method (literature-reported solubility &lt; 0.1 μg/mL [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]).</p></section><section id="Sec7"><h4 class="pmc_sec_title">Structure–activity relationship analysis</h4>
<p id="Par9">As presented in Table <a href="#Tab2" class="usa-link">2</a>, the majority of tanshinone I-pyridinium salt derivatives showed the potential inhibitory activity. A series of newly synthesized tanshinone I-pyridinium salt derivatives displayed markedly higher in vitro cytotoxic activity than the unmodified parent compound (<strong>a1</strong>), indicating that incorporation of a pyridinium moiety is critical for enhancing the anticancer activity of tanshinone I. Specifically, the nature of the substituent at the <em>N</em>-1 position of the pyridine ring profoundly influenced antitumor potency. Pyridinium salts bearing an acyl-linked substituent at <em>N</em>-1 (e.g., a benzoylmethyl group) were significantly more potent than those with benzyl or alkyl linkers. Notably, the pyridinium salt derivative with a 4-bromobenzoylmethyl substituent (<strong>a4</strong>) exhibited the best potent cytotoxic activity (IC<sub>50</sub> = 1.40–1.63 µM). Moreover, the electron-withdrawing 4-bromobenzoylmethyl group (<strong>a4</strong>) conferred greater potency than the electron-donating 4-methoxybenzoylmethyl substituent (<strong>a5</strong>), demonstrating that electron-withdrawing substituent was more favorable for cytotoxic activity. In addition, compounds with a single aromatic-ring substituent generally showed higher activity than those with disubstituted rings, and the substituent’s position had a pronounced effect. For example, the 2-bromobenzyl derivative (<strong>a9</strong>) exhibited higher potency than the 2-bromo-4-nitrobenzyl derivative (<strong>a19</strong>). Furthermore, the meta-substituted analog (<strong>a7</strong>) was significantly more active than the ortho-substituted counterpart (<strong>a15</strong>), this highlights the importance of substituent position. Additionally, naphthalene analogs featuring an acylmethyl linker were more active than those lacking this moiety, further highlighting the key influence of linker structure on cytotoxic potency. Conversely, an aliphatic substituent (isobutenyl in <strong>a22</strong>) yielded much lower activity than aromatic substituents, indicating that such chain substituents provide limited benefit for antitumor potency.</p>
<p id="Par10">In summary, <em>SAR</em> analysis demonstrates that introducing a pyridinium fragment is pivotal for boosting the activity of tanshinone I derivatives. The linkage mode of the N-1 substituent, the electronic nature and position of aromatic substituents significantly impact in vitro cytotoxic activity. These results offer an important theoretical basis for further structural optimization. The preliminary structure activity relationships (<em>SARs</em>) of the pyridinium salt derivatives were summarized in Scheme <a href="#Sch2" class="usa-link">2</a>.</p>
<figure class="fig xbox font-sm" id="Sch2"><h5 class="obj_head">Scheme 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Sch2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/6ae973fea685/13659_2025_534_Sch2_HTML.jpg" loading="lazy" id="MO5" height="863" width="786" alt="Scheme 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Sch2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Structure–activity relationships (<em>SARs</em>) of tanshinone I Derivatives</p></figcaption></figure></section></section><section id="Sec8"><h3 class="pmc_sec_title">Compound a4 induces apoptosis and migration</h3>
<p id="Par11">To elucidate the potential mechanism underlying the antiproliferative effect of compound <strong>a4</strong>, cell cycle progression and apoptosis were analyzed by flow cytometry. Compound <strong>a4</strong> induced apoptosis by was assessed using Annexin V-FITC/PI double staining assay. As shown in Fig. <a href="#Fig3" class="usa-link">3</a>, treatment of MDA-MB-231 cells with compound <strong>a4</strong> at 1, 2, and 4 μM for 48 h significantly increased apoptosis rates to 2.69%, 11.48%, and 75.81%, respectively. These results indicate that compound <strong>a4</strong> induced apoptosis in MDA-MB-231 cells in a dose-dependent manner.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/7e70d2805578/13659_2025_534_Fig3_HTML.jpg" loading="lazy" id="MO6" height="206" width="783" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Compound <strong>a4</strong> induced apoptosis of MDA-MB-231 cells. <strong>A</strong> Cells were treated with 1, 2 and 4 μM compound <strong>a4</strong> for 48 h. Cell apoptosis was determined by Annexin V-FITC/Propidium Iodide staining analysis. <strong>B</strong> The quantification of apoptotic cells</p></figcaption></figure><p id="Par12">Further, the effect of compound <strong>a4</strong> on the cell cycle distribution of MDA-MB-231 cells was investigated at concentrations of 0.5, 1, and 2 μM. Cell cycle analysis by PI staining and flow cytometry revealed that compound <strong>a4</strong> caused no significant cell cycle arrest in MDA-MB-231 cells (Fig. <a href="#Fig4" class="usa-link">4</a>). Collectively, apoptosis induction rather than cell cycle arrest primarily contributed to its anticancer activity of compound <strong>a4</strong>.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/fc67d53eb128/13659_2025_534_Fig4_HTML.jpg" loading="lazy" id="MO7" height="200" width="784" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Compound <strong>a4</strong> did not induce significant cell cycle arrest in MDA-MB-231 cells. <strong>A</strong> Cells were treated with different concentrations of compound <strong>a4</strong> (0.5 μM, 1 μM, 2 μM) for 24 h, and cell cycle was determined by cell cytometry with PI staining. <strong>B</strong> The percentages of cells in different phases were quantified</p></figcaption></figure><p id="Par13">Scratch wound healing assay was conducted to test whether <strong>a4</strong> impaired the migration of MDA-MB-231 cells. The migration rates at 24 h of MDA-MB-231 cells decreased with the increasing <strong>a4</strong> in Fig. <a href="#Fig5" class="usa-link">5</a>.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/2118f7df146b/13659_2025_534_Fig5_HTML.jpg" loading="lazy" id="MO8" height="370" width="784" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Compound <strong>a4</strong> inhibited migration of MDA-MB-231 cells. MDA-MB-231 cells were exposed to <strong>a4</strong>, and the migration was evaluated with wound healing assay, with the representative images were taken and relative migration rates were calculated respectively. Scale indicates 500 μm</p></figcaption></figure></section><section id="Sec9"><h3 class="pmc_sec_title">Compound a4 suppresses PI3K/mTOR and PD-L1</h3>
<p id="Par14">The PI3K/Akt/mTOR signaling ranks one of the most frequently dysregulated signaling pathways in cancer by promoting tumor initiation and progression [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Further, abnormal PI3K/AKT/mTOR pathway activation resulted PD-L1 increase facilitates the escape of cancer cells from the immunosurveillance of immune system [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Thus, the PI3K/Akt/mTOR signaling components such as PI3K and mTOR are potential therapeutic targets in cancer, and the identification of PI3K/Akt/mTOR signaling inhibitors have drawn extensive attention. In particular, the PI3K has four subtypes (α/β/γ/δ), while overexpression and mutation resulted abnormal activation of PI3Kα is closely to the progression of solid cancers, therefore, PI3Kα has become a key target for the development of anticancer drugs. To date, alpelisib is the only PI3Kα inhibitor approved for the treatment of breast cancer, and several other PI3Kα inhibitors are under evaluation in clinical trials [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>], which give us proposal for the development of novel PI3Kα inhibitors for tumor therapy.</p>
<p id="Par15">To further elucidate the underlying mechanism of compound <strong>a4</strong>, molecular docking analysis was performed to identify potential target-proteins and subsequent biological experiments were conducted to confirm the precise target predicted. Molecular docking analysis of compound <strong>a4</strong> with putative targets revealed strong binding affinities toward PI3Kα (Fig. <a href="#Fig6" class="usa-link">6</a>A). The compound binds within the PI3Kα active site, forming a hydrogen bond (2.2 Å) between its benzoyl oxygen and the LYS802 residue. The conjugated polycyclic framework of compound <strong>a4</strong> contributes significantly to binding through multiple π-π stacking interactions: two with the benzene ring of TPR780 (4.8 Å and 5.2 Å) and one with TYR836 involving the compound’s furan ring (5.0 Å). Additionally, hydrophobic π-sulfur interactions are observed between the conjugated system of compound <strong>a4</strong> and the sulfur atom of MET922 (4.1 Å and 3.9 Å).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332164_13659_2025_534_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f8/12332164/0ea16a00b76e/13659_2025_534_Fig6_HTML.jpg" loading="lazy" id="MO9" height="754" width="784" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Compound <strong>a4 of</strong> mechanistic studies. (<strong>A</strong>) Molecular docking of PI3Kα protein (PDB ID: 4JPS). (<strong>B</strong>) The compound <strong>a4</strong> inhibits the PI3Kα activity. (<strong>C</strong>) PI3K regulates downstream signaling pathways and PD-L1 protein expression. (<strong>D</strong>) Statistical analysis of the Western blot experimental section, The asterisk (*) represents a statistically significant difference when compared to indicated sample (*p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001 and ****p &lt; 0.0001). Error bars represent the standard deviation (SD) of the mean</p></figcaption></figure><p id="Par16">To further confirm the interaction of <strong>a4</strong> and PI3Kα, the PI3Kα inhibitory of <strong>a4</strong> was performed. As shown in Fig. <a href="#Fig6" class="usa-link">6</a>B, <strong>a4</strong> inhibited PI3Kα in a dose dependent manner, with an IC<sub>50</sub> of 9.24 ± 0.20 μM, indicating <strong>a4</strong> was a novel PI3Kα inhibitor. Subsequent western blot analysis demonstrated that compound <strong>a4</strong> exerts dual regulatory effects on the PI3K/Akt/mTOR pathway and tumor immune microenvironment by analyzing key signaling proteins and immune checkpoint molecules (Fig. <a href="#Fig6" class="usa-link">6</a>C, D). Using the PI3K inhibitor GDC0032 as a positive control, Western blot results demonstrated that <strong>a4</strong>, while showing no impact on total protein levels of AKT, S6K, or S6, exerted concentration-dependent inhibition on phospho-AKT (Ser473), phospho-S6K (Thr389), and phospho-S6 (Ser235/236), indicating <strong>a4</strong> effectively blocks PI3K/AKT/mTOR signaling. Notably, <strong>a4</strong> exhibited enhanced PD-L1 downregulation. These findings establish a “pathway inhibition-immunoactivation” synergy, offering a novel therapeutic strategy against tumor immune evasion.</p></section></section><section id="Sec10"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par17">In summary, we have successfully designed and synthesized a series of novel tanshinone I-pyridinium salt derivatives. This method enabled the rapid construction of structurally diverse tanshinone I-pyridinium hybrid molecules, and in vitro activity evaluation demonstrated that these derivatives exhibit potential antitumor activity. Notably, <em>SARs</em> revealed that the pyridinium moiety was identified as the critical structural feature responsible for the enhanced in vitro cytotoxic activity of the tanshinone I derivatives. Compound <strong>a4</strong>, featuring a 4-bromobenzoylmethyl substituent at the <em>N</em>-1 position of the pyridine ring, was the most active derivative in the series, with IC<sub>50</sub> values of 1.41, 1.63 and 1.40 μM against human cancer cell lines MDA-MB-231, HepG2 and 22RV1, respectively, indicating that <strong>a4</strong> exhibited the most potent antitumor activity among all derivatives. Meanwhile, compound <strong>a4</strong> demonstrated markedly improved aqueous solubility (85 μg/mL). Furthermore, cell cycle, apoptosis and migration studies indicated that <strong>a4</strong> induces cell cycle arrest, apoptosis and migration inhibition in the MDA-MB-231 breast cancer cell line in a markedly dose-dependent manner. Preliminary mechanistic studies suggest that compound <strong>a4</strong> is a novel PI3Kα inhibitor and exerts its antitumor effects through a dual mechanism. On one hand, it effectively inhibits the phosphorylation of downstream key proteins in the PI3K/Akt/mTOR signaling pathway; on the other hand, it significantly downregulates the expression of the immune checkpoint protein PD-L1. These findings not only provide an efficient structural optimization strategy for the development of tanshinone I-based anticancer agents, but also suggest that compound <strong>a4</strong> is a promising candidate for further antitumor studies.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Methods and materials</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Chemistry experimental materials</h3>
<p id="Par18">Melting points were obtained and uncorrected on a Haineng melting-point apparatus. Proton nuclear magnetic resonance (<sup>1</sup>H-NMR) spectra were recorded on a Bruker Avance 400 and Bruker Avance 600 spectrometers at 400 MHz and 600 MHz. Carbon-13 nuclear magnetic resonance (<sup>13</sup>C-NMR) was recorded on Bruker Avance 400 spectrometer at 100 MHz. Carbon-13 nuclear magnetic resonance (<sup>13</sup>C-NMR) was recorded on Bruker Avance 600 spectrometer at 150 MHz. Chemical shifts are reported as δ values in parts per million (ppm) relative to tetramethylsilane (TMS) for all recorded NMR spectra. High Resolution Mass spectra were taken on Thermo Fisher LC-MSO/TOR mass spectrometer. Silica gel (200–300 mesh) for column chromatography and silica GF254 for TLC were produced by Qingdao Marine Chemical Company (China). All air- or moisture- sensitive reactions were conducted under an argon atmosphere. Starting materials and reagents used in reactions were obtained commercially from TCI, Adamas, Aladdin, Bidepharm and were used without purification, unless otherwise indicated. Purity of all compounds was determined by high-performance liquid chromatography (HPLC) using an Agilent instrument.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Synthesis of compounds a2-a22</h3>
<section id="Sec14"><h4 class="pmc_sec_title">Synthesis of compounds a2</h4>
<p id="Par19">Compound <strong>a1</strong> (0.10 g, 0.36 mmol) was dissolved in 20 mL of analytical-grade acetic acid in a 50 mL microwave tube. Ammonium acetate (0.11 g, 1.45 mmol) was added, followed by the dropwise addition of 3-pyridinecarbaldehyde (0.051 mL, 0.54 mmol) at room temperature. The mixture was stirred for 10 min, then heated to 100 °C in a microwave reactor and maintained for 1 h. After cooling to room temperature, the solution was transferred to a 100 mL round-bottom flask and neutralized to pH 7 using saturated aqueous NaOH. The neutralized mixture was extracted with ethyl acetate (3 × 30 mL), and the aqueous phase was further extracted with ethyl acetate (3 × 30 mL). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (silica gel, eluent: dichloromethane/ethyl acetate = 10:1 → 5:1, v/v, containing 1% (v/v) formic acid) to afford <strong>a2</strong> as yellow powder in 76% yield. (Experimental findings &amp; Structural elucidation of <strong>a2</strong> are included in the Supporting information)</p>
<p id="Par20"><em>4.2.1.1 1,6-dimethyl-11-(pyridin-3-yl)-12H-furo[2',3':1,2]phenanthro[3,4-d] imidazole (</em><strong><em>a2</em></strong><em>).</em> Yield 76%. Yellow powder, m.p. 288–289 °C. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 10.74 (d, <em>J</em> = 9.0 Hz, 1H), 9.58 (d, <em>J</em> = 1.8 Hz, 1H), 8.79 (d, <em>J</em> = 7.8 Hz, 1H), 8.62 (dd, <em>J</em> = 4.8, 1.2 Hz, 1H), 8.29 (d, <em>J</em> = 9.0 Hz, 1H), 8.06 (d, <em>J</em> = 9.0 Hz, 1H), 7.96 (d, <em>J</em> = 1.8 Hz, 1H), 7.63 (dd, <em>J</em> = 8.4, 6.6 Hz, 1H), 7.57 (dd, <em>J</em> = 8.4, 4.8 Hz, 1H), 7.45 (d, <em>J</em> = 7.2 Hz, 1H), 2.70 (s, 3H), 2.60 (d, <em>J</em> = 1.2 Hz, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 150.0, 149.0, 148.2, 146.8, 146.7, 142.1, 136.7, 134.5, 134.0, 130.6, 130.3, 127.2, 126.8, 126.6, 126.5, 123.9, 122.1, 119.2, 119.0, 115.9, 115.6, 112.9, 20.0, 10.0 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>24</sub>H<sub>18</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 364.1444, found 364.1447. HPLC purity: 98.6%.</p></section><section id="Sec15"><h4 class="pmc_sec_title">Synthesis of compounds a3-a22</h4>
<p id="Par21">Compound <strong>a2</strong> (0.05 g, 0.14 mmol) was charged into a 50 mL round-bottom flask and dissolved in ultra-dry acetonitrile (20 mL). The mixture was heated under reflux at 100 °C for 12 h until complete dissolution of <strong>a2</strong> was achieved. Subsequently, various bromides (5.0 equiv relative to <strong>a2</strong>) were introduced sequentially, each dissolved in ultra-dry acetonitrile (20 mL per 50 mg substrate). The reaction mixtures were refluxed with stirring for an additional 24–48 h and monitored by TLC. Upon completion, solvents were removed under reduced pressure, and the precipitated solid was collected by filtration, thoroughly washed with ethyl acetate (3 × 60 mL), and dried under vacuum at 60 °C to afford tanshinone I-pyridinium derivatives <strong>a3-a22</strong> as yellow powder in 36–97% yields. (Structural determination for representative derivative <strong>a4</strong> is detailed in the Supporting information)</p>
<p id="Par22"><em>4.2.2.1 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(2-oxo-2-phenylethyl) pyridin-1-ium bromide (</em><strong><em>a3</em></strong><em>).</em> Yield 85%. Yellow powder, m.p. 287–288 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3429, 3048, 2959, 1703, 1624, 1449, 1369, 1341, 1319, 1218, 1087, 798, 780, 704, 685, 590. <sup><strong>1</strong></sup><strong>H NMR</strong> (400 MHz, DMSO-<em>d</em><sub>6</sub>) δ 10.67 (d, <em>J</em> = 8.8 Hz, 1H), 9.96 (s, 1H), 9.49 (d, <em>J</em> = 8.4 Hz, 1H), 9.07 (d, <em>J</em> = 6.0 Hz, 1H), 8.49 (dd, <em>J</em> = 8.0, 6.0 Hz, 1H), 8.34 (d, <em>J</em> = 9.2 Hz, 1H), 8.20—8.13 (m, 3H), 8.04 (d, <em>J</em> = 1.2 Hz, 1H), 7.89—7.82 (m, 1H), 7.75 – 7.66 (m, 3H), 7.51 (d, <em>J</em> = 6.8 Hz, 1H), 6.71 (s, 2H), 2.76 (s, 3H), 2.61 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (100 MHz, DMSO-<em>d</em><sub>6</sub>) δ 190.8, 149.6, 145.4, 144.4, 142.4, 142.4, 142.3, 136.7, 135.0, 134.1, 133.6 130.6, 130.2, 130.0, 129.2, 128.4, 127.8, 127.3, 126.9, 126.8, 126.7, 122.7, 119.2, 118.8, 116.4, 115.4, 112.5, 66.9, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>32</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub> [M]<sup>+</sup> 482.1863, found 482.1867. HPLC purity: 97.7%.</p>
<p id="Par23"><em>4.2.2.2 1-(2-(4-bromophenyl)-2-oxoethyl)-3-(1,6-dimethyl-12H-furo[2',3':1,2]phenanthro[3,4-d]imidazol-11-yl) pyridin-1-ium bromide (</em><strong><em>a4</em></strong><em>)</em>. Yield 76%. Yellow powder, m.p. 268–269 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3429,3040, 2951, 1702, 1584, 1396, 1336, 1216, 1098, 998, 821, 727, 705, 688, 591. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.48 (s, 1H), 10.68 (d, <em>J</em> = 8.4 Hz, 1H), 9.96 (s, 1H), 9.52 (d, <em>J</em> = 8.4 Hz, 1H), 9.06 (d, <em>J</em> = 6.0 Hz, 1H), 8.50 (dd, <em>J</em> = 8.4, 6.0 Hz, 1H), 8.36 (d, <em>J</em> = 9.0 Hz, 1H), 8.17 (d, <em>J</em> = 9.0 Hz, 1H), 8.09 (d, <em>J</em> = 8.4 Hz, 2H), 8.06 (d, <em>J</em> = 1.2 Hz, 1H), 7.95 (d, <em>J</em> = 8.4 Hz, 2H), 7.69 (dd, <em>J</em> = 8.4, 7.2 Hz, 1H), 7.52 (d, <em>J</em> = 7.2 Hz, 1H), 6.69 (s, 2H), 2.77 (s, 3H), 2.63 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 190.2, 149.6, 145.4, 144.4, 142.5, 142.4, 142.4, 136.7, 134.1, 132.7, 132.4, 130.6, 130.4, 130.3, 130.0, 129.0, 127.8, 127.3, 127.0, 126.7, 126.6, 122.7, 119.2, 118.8, 116.4, 115.4, 112.5, 66.8, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>32</sub>H<sub>23</sub>O<sub>2</sub>N<sub>3</sub>Br [M]<sup>+</sup> 560.0968, found 560.0973. HPLC purity: 98.1%.</p>
<p id="Par24"><em>4.2.2.3 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(2-(4-methoxyphenyl)-2-oxoethyl) pyridin-1-ium bromide (</em><strong><em>a5</em></strong><em>).</em> Yield 90%. Yellow powder, m.p. 326–327 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3419, 3048, 2943, 1688, 1623, 1598, 1263, 1174, 1022, 838, 704, 678, 593. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.53 (s, 1H), 10.71 (d, <em>J</em> = 9.0 Hz, 1H), 9.97 (s, 1H), 9.54 (d, <em>J</em> = 8.4 Hz, 1H), 9.08 (d, <em>J</em> = 6.0 Hz, 1H), 8.50 (dd, <em>J</em> = 7.8, 6.0 Hz, 1H), 8.37 (d, <em>J</em> = 9.0 Hz, 1H), 8.18 (d, <em>J</em> = 9.0 Hz, 1H), 8.13 (d, <em>J</em> = 8.4 Hz, 2H), 8.08 (d, <em>J</em> = 1.8 Hz, 1H), 7.71—7.67 (m, 1H), 7.53 (d, <em>J</em> = 7.2 Hz, 1H), 7.24 (d, <em>J</em> = 8.4 Hz, 2H), 6.65 (s, 2H), 3.93 (s, 3H), 2.78 (s, 3H), 2.64 (d, <em>J</em> = 1.2 Hz, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 189.0, 164.4, 149.6, 145.5, 144.5, 142.6, 142.5, 142.3, 142.1, 136.7, 134.2, 130.9, 130.6, 130.3, 130.0, 127.8, 127.3, 127.0, 126.8, 126.6, 126.4, 126.4, 122.7, 119.2, 118.8, 116.5, 115.4, 114.5, 112.6, 66.7, 55.9, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>33</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> [M]<sup>+</sup> 512.1969, found 512.1965. HPLC purity: 96.1%.</p>
<p id="Par25"><em>4.2.2.4 3-(1,6-dimethyl-12H-furo[2',3':1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(2-(naphthalen-2-yl)-2-oxoethyl) pyridin-1-ium bromide (</em><strong><em>a6</em></strong><em>).</em> Yield 36%. Yellow powder, m.p. 292–293 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3423, 3051, 2922, 1698, 1624, 1467, 1357, 1316, 1278, 1176, 1146, 866, 821, 705, 677. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.63 (s, 1H), 10.74 (d, <em>J</em> = 9.0 Hz, 1H), 10.05 (s, 1H), 9.61 (d, <em>J</em> = 7.8 Hz, 1H), 9.14 (d, <em>J</em> = 6.0 Hz, 1H), 8.94 (d, <em>J</em> = 1.8 Hz, 1H), 8.56 (dd, <em>J</em> = 8.4, 6.0 Hz, 1H), 8.40 (d, <em>J</em> = 9.0 Hz, 1H), 8.29 (d, <em>J</em> = 7.8 Hz, 1H), 8.21 (d, <em>J</em> = 9.0 Hz, 2H), 8.14—8.11 (m, 3H), 7.81—7.78 (m, 1H), 7.76—7.73 (m, 1H), 7.68 (dd, <em>J</em> = 8.4, 7.2 Hz, 1H), 7.53 (d, <em>J</em> = 7.2 Hz, 1H), 6.83 (s, 2H), 2.78 (s, 3H), 2.68 (d, <em>J</em> = 1.2 Hz, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 191.1, 150.1, 146.0, 145.1, 143.2, 143.0, 137.3, 136.2, 134.7, 132.5, 131.4, 131.3, 131.1, 130.9, 130.5, 130.3, 130.1, 129.4, 128.5, 128.4, 128.1, 127.8, 127.5, 127.2, 127.0, 123.8, 123.2, 119.7, 119.3, 117.0, 115.9, 113.1, 67.4, 20.3, 10.2 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>36</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> [M]<sup>+</sup> 532.2020, found 532.2020. HPLC purity: 95.9%.</p>
<p id="Par26"><em>4.2.2.5 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(3-methylbenzyl) pyridin-1-ium bromide (</em><strong><em>a7</em></strong><em>).</em> Yield 67%. Yellow powder, m.p. 280–281 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3377, 3006, 1590, 1397, 1302, 1161, 819, 712, 593. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 10.57 (s, 1H), 10.06 (s, 1H), 9.30 (s, 1H), 9.21 (s, 1H), 8.34 (d, <em>J</em> = 7.2 Hz, 1H), 8.27 (d, <em>J</em> = 9.0 Hz, 1H), 8.08 (d, <em>J</em> = 9.0 Hz, 1H), 7.96 (s, 1H), 7.67 (t, <em>J</em> = 7.8 Hz, 1H), 7.56 (s, 1H), 7.53 (d, <em>J</em> = 7.2 Hz, 1H), 7.49 (d, <em>J</em> = 6.6 Hz, 1H), 7.45 (t, <em>J</em> = 7.2 Hz, 1H), 7.33 (d, <em>J</em> = 6.0 Hz, 1H), 6.05 (s, 2H), 2.74 (s, 3H), 2.57 (s, 3H), 2.38 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO) δ 149.8, 144.0, 142.9, 142.6, 142.1, 139.2, 136.9, 134.4, 134.4, 131.2, 130.9, 130.6, 130.3, 130.1, 129.7, 128.7, 127.6, 127.0, 126.9, 126.7, 122.8, 119.4, 119.2, 116.7, 115.8, 113.0, 64.0, 21.4, 20.3, 10.3. ppm; <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>32</sub>H<sub>26</sub>N<sub>3</sub>O [M]<sup>+</sup> 468.2070, found 468.2074. HPLC purity: 97.6%.</p>
<p id="Par27"><em>4.2.2.6 1-(2-cyanobenzyl)-3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl) pyridin-1-ium bromide (</em><strong><em>a8</em></strong><em>).</em> Yield 84%. Yellow powder, m.p. 285–286 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3426, 3069, 3028, 2961, 2919, 2854, 2223, 1878, 1624, 1489, 1456, 1314, 1146, 816, 773, 702, 686. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.54 (s, 1H), 10.68 (d, <em>J</em> = 8.4 Hz, 1H), 10.06 (d, <em>J</em> = 1.8 Hz, 1H), 9.51 (d, <em>J</em> = 7.8 Hz, 1H), 9.22 (d, <em>J</em> = 6.0 Hz, 1H), 8.47 (dd, <em>J</em> = 7.8, 6.0 Hz, 1H), 8.36 (d, <em>J</em> = 9.0 Hz, 1H), 8.18 (d, <em>J</em> = 9.0 Hz, 1H), 8.11 (dd, <em>J</em> = 7.8, 1.2 Hz, 1H), 8.07 (d, <em>J</em> = 1.8 Hz, 1H), 7.88 (td, <em>J</em> = 7.8, 1.2 Hz, 1H), 7.74—7.67 (m, 3H), 7.55 (d, <em>J</em> = 7.2 Hz, 1H), 6.37 (s, 2H), 2.78 (s, 3H), 2.63 (d, <em>J</em> = 1.2 Hz, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.6, 144.2, 143.6, 142.5, 142.4, 142.2, 137.0, 136.7, 134.3, 134.1, 134.0, 130.9, 130.6, 130.2, 130.0, 129.8, 128.7, 127.3, 127.0, 126.7, 126.6, 122.8, 119.1, 118.8, 117.1, 116.5, 115.4, 112.6, 111.5, 61.9, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>32</sub>H<sub>23</sub>N<sub>4</sub>O [M]<sup>+</sup> 479.1866, found 479.1870. HPLC purity: 97.9%.</p>
<p id="Par28"><em>4.2.2.7 1-(2-bromobenzyl)-3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl) pyridin-1-ium bromide (</em><strong><em>a9</em></strong><em>).</em> Yield 69%. Yellow powder, m.p. 260–261 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3423, 3083, 3006, 2933, 2860, 1805, 1627, 1491, 1473, 1371, 1165, 1048, 1027, 812, 757, 679. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.55 (s, 1H), 10.62 (d, <em>J</em> = 8.4 Hz, 1H), 9.98 (s, 1H), 9.51 (d, <em>J</em> = 8.4 Hz, 1H), 9.19 (d, <em>J</em> = 6.0 Hz, 1H), 8.46 (t, <em>J</em> = 7.2 Hz, 1H), 8.37 (d, <em>J</em> = 9.0 Hz, 1H), 8.19 (d, <em>J</em> = 9.0 Hz, 1H), 8.08 (s, 1H), 7.89 (d, <em>J</em> = 7.8 Hz, 1H), 7.70 (t, <em>J</em> = 7.8 Hz, 1H), 7.63—7.55 (m, 3H), 7.51 (d, <em>J</em> = 7.2 Hz, 1H), 6.19 (s, 2H), 2.79 (s, 3H), 2.64 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.6, 144.2, 143.1, 142.5, 142.4, 142.1, 136.7, 134.2, 133.6, 133.1, 131.8, 131.6, 130.7, 130.6, 129.9, 128.9, 128.6, 127.4, 127.0, 126.7, 126.5, 123.6, 122.8, 119.1, 118.8, 116.5, 115.4, 112.6, 63.7, 19.9, 9.7 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>31</sub>H<sub>23</sub>N<sub>3</sub>OBr [M]<sup>+</sup> 532.1019, found 532.1024. HPLC purity: 98.9%.</p>
<p id="Par29"><em>4.2.2.8 1-(4-bromobenzyl)-3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl) pyridin-1-ium bromide (</em><strong><em>a10</em></strong><em>).</em> Yield 89%. Yellow powder, m.p. 285–286 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3382, 3091, 3037, 2993, 2927, 1904, 1584, 1484, 1442, 1351, 1169, 1071, 838, 814, 649. <sup><strong>1</strong></sup><strong>H NMR</strong> (400 MHz, DMSO-<em>d</em><sub>6</sub>) δ 10.57 (d, <em>J</em> = 8.4 Hz, 1H), 10.07 (s, 1H), 9.30 (d, <em>J</em> = 8.0 Hz, 1H), 9.21 (d, <em>J</em> = 6.0 Hz, 1H), 8.35 (dd, <em>J</em> = 8.4, 6.0 Hz, 1H), 8.27 (d, <em>J</em> = 9.2 Hz, 1H), 8.09 (d, <em>J</em> = 9.2 Hz, 1H), 8.00—7.94 (m, 1H), 7.78 (d, <em>J</em> = 8.4 Hz, 2H), 7.72 (d, <em>J</em> = 8.4 Hz, 2H), 7.68 (dd, <em>J</em> = 8.8, 7.2 Hz, 1H), 7.49 (d, <em>J</em> = 6.8 Hz, 1H), 6.09 (s, 2H), 2.74 (s, 3H), 2.56 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (100 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.5, 143.7, 142.7, 142.2, 141.7, 136.5, 134.0, 133.3, 132.3, 131.6, 130.6, 130.5, 129.9, 128.4, 127.2, 126.7, 126.6, 123.2, 122.5, 119.0, 118.7, 116.3, 115.3, 112.4, 62.8, 19.9, 9.9 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>31</sub>H<sub>23</sub>N<sub>3</sub>OBr [M]<sup>+</sup> 532.1019, found 532.1022. HPLC purity: 98.0%.</p>
<p id="Par30"><em>4.2.2.9 1-(4-chlorobenzyl)-3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl) pyridin-1-ium bromide (</em><strong><em>a11</em></strong><em>).</em> Yield 92%. Yellow powder, m.p. 261–262 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3422, 3092, 3038, 2923, 2853, 1629, 1594, 1489, 1399, 1283, 1143, 1088, 842, 776, 700, 677. <sup><strong>1</strong></sup><strong>H NMR</strong> (400 MHz, DMSO-<em>d</em><sub>6</sub>) δ 10.59 (d, <em>J</em> = 8.4 Hz, 1H), 10.08 (s, 1H), 9.32 (d, <em>J</em> = 8.4 Hz, 1H), 9.21 (d, <em>J</em> = 6.0 Hz, 1H), 8.36 (dd, <em>J</em> = 8.0, 2.0 Hz, 1H), 8.28 (d, <em>J</em> = 9.2 Hz, 1H), 8.10 (d, <em>J</em> = 9.2 Hz, 1H), 7.99 (d, <em>J</em> = 1.6 Hz, 1H), 7.83—7.76 (m, 2H), 7.71—7.66 (m, 1H), 7.66—7.62 (m, 2H), 7.50 (d, <em>J</em> = 6.8 Hz, 1H), 6.11 (s, 2H), 2.75 (s, 3H), 2.58 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (101 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.5, 143.7, 142.7, 142.3, 141.8, 136.5, 134. 5, 134.0, 132.9, 131.4, 130.6, 130.5, 129.9, 129.4, 128.4, 127.2, 126.8, 126.6, 122.6, 119.0, 118.7, 116.4, 115.3, 112.5, 62.7, 19.9, 9.9 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>31</sub>H<sub>23</sub>ON<sub>3</sub>Cl [M]<sup>+</sup> 488.1524, found 488.1526. HPLC purity: 96.2%.</p>
<p id="Par31"><em>4.2.2.10 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(4-fluorobenzyl) pyridin-1-ium bromide (</em><strong><em>a12</em></strong><em>).</em> Yield 97%. Yellow powder, m.p. 276–277 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3426, 3009, 2941, 1627, 1591, 1526, 1318, 1228, 1160, 1144, 818, 773, 707, 684. <sup><strong>1</strong></sup><strong>H NMR</strong> (400 MHz, DMSO-<em>d</em><sub>6</sub>) δ 10.63 (d, <em>J</em> = 8.4 Hz, 1H), 10.08 (s, 1H), 9.38 (d, <em>J</em> = 8.4 Hz, 1H), 9.22 (d, <em>J</em> = 5.6 Hz, 1H), 8.38 (dd, <em>J</em> = 8.4, 6.0 Hz, 1H), 8.33 (d, <em>J</em> = 9.2 Hz, 1H), 8.15 (d, <em>J</em> = 9.2 Hz, 1H), 8.04 (d, <em>J</em> = 1.6 Hz, 1H), 7.87—7.81 (m, 2H), 7.71 (dd, <em>J</em> = 8.8, 6.8 Hz, 1H), 7.54 (d, <em>J</em> = 6.8 Hz, 1H), 7.45—7.39 (m, 2H), 6.09 (s, 2H), 2.77 (s, 3H), 2.63—2.60 (m, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (100 MHz, DMSO-<em>d</em><sub>6</sub>) δ 162.79 (d, <sup>1</sup><em>J</em><sub>C-F</sub> = 244.9 Hz), 149.6, 143.7, 142.7, 142.44, 142.38, 141.8, 136.6, 134.1, 132.0 (d, <sup>3</sup><em>J</em><sub>C-F</sub> = 8.5 Hz), 130.6, 130.60, 130.2 (d, <sup>4</sup><em>J</em><sub>C-F</sub> = 3.1 Hz), 130.0, 128.4, 127.3, 126.8, 126.6, 122.7, 119.1, 118.8, 116.3 (d, <sup>2</sup><em>J</em><sub>C-F</sub> = 21.8 Hz), 115.4, 112.5, 62.8, 19.9, 9.9 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>31</sub>H<sub>23</sub>ON<sub>3</sub>F [M]<sup>+</sup> 472.1820, found 472.1818. HPLC purity: 98.6%.</p>
<p id="Par32"><em>4.2.2.11 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(4-(trifluoromethyl) benzyl)pyridin-1-ium bromide (</em><strong><em>a13</em></strong><em>).</em> Yield 85%. Yellow powder, m.p. 273–274 ℃. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.55 (s, 1H), 10.70 (d, <em>J</em> = 8.4 Hz, 1H), 10.16 (s, 1H), 9.48 (d, <em>J</em> = 8.4 Hz, 1H), 9.23 (d, <em>J</em> = 6.0 Hz, 1H), 8.43 (dd, <em>J</em> = 8.4, 6.0 Hz, 1H), 8.37 (d, <em>J</em> = 9.0 Hz, 1H), 8.19 (d, <em>J</em> = 9.0 Hz, 1H), 8.08 (d, <em>J</em> = 1.8 Hz, 1H), 7.95—7.88 (m, 4H), 7.72 (dd, <em>J</em> = 8.4, 6.6 Hz, 1H), 7.56 (d, <em>J</em> = 6.6 Hz, 1H), 6.22 (s, 2H), 2.79 (s, 3H), 2.65 (d, <em>J</em> = 1.2 Hz, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.6, 144.1, 143.3, 142.6, 142.5, 142.2, 138.6, 136.7, 134.2, 130.6 (q, <sup>2</sup><em>J</em><sub>C-F</sub> = 35.9 Hz), 129.7, 130.0, 129.9, 128.6, 127.4, 126.9, 126.7 (q, <sup>3</sup><em>J</em><sub>C-F</sub> = 9.15 Hz), 126.2 (q, <sup>4</sup><em>J</em><sub>C-F</sub> = 3.9 Hz), 124.0 (q, <sup>1</sup><em>J</em><sub>C-F</sub> = 270.8 Hz), 122.7, 119.2, 118.8, 116.5, 115.4, 112.6, 62.9, 19.9, 9.8 ppm; <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>32</sub>H<sub>23</sub>N<sub>3</sub>OF<sub>3</sub> [M]<sup>+</sup> 522.1788, found 522.1788. HPLC purity: 97.0%.</p>
<p id="Par33"><em>4.2.2.12 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(4-formylbenzyl) pyridin-1-ium bromide (</em><strong><em>a14</em></strong><em>).</em> Yield 74%. Yellow powder, m.p. 243–244 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3424, 3076, 2926, 2851, 1696, 1624, 1455, 1211, 1170, 814, 778, 702, 682, 594. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.52 (s, 1H), 10.68 (d, <em>J</em> = 9.0 Hz, 1H), 10.15 (s, 1H), 10.08 (s, 1H), 9.47 (d, <em>J</em> = 8.4 Hz, 1H), 9.24 (d, <em>J</em> = 6.0 Hz, 1H), 8.43 (dd, <em>J</em> = 8.4, 6.0 Hz, 1H), 8.36 (d, <em>J</em> = 9.0 Hz, 1H), 8.18 (d, <em>J</em> = 9.0 Hz, 1H), 8.09—8.03 (m, 3H), 7.88 (d, <em>J</em> = 7.8 Hz, 2H), 7.71 (t, <em>J</em> = 7.8 Hz, 1H), 7.55 (d, <em>J</em> = 7.2 Hz, 1H), 6.23 (s, 2H), 2.78 (s, 3H), 2.68—2.59 (m, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 192.9, 149.6, 144.1, 143.3, 142.5, 142.4, 142.2, 140.2, 136.7, 136.6, 134.2, 130.9, 130.6, 130.3, 130.0, 129.6, 128.6, 127.3, 126.9, 126.7, 126.6, 122.7, 119.6, 118.8, 116.5, 115.4, 112.6, 63.2, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>32</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub> [M]<sup>+</sup> 482.1863, found 482.1866.</p>
<p id="Par34"><em>4.2.2.13 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(4-methylbenzyl) pyridin-1-ium bromide (</em><strong><em>a15</em></strong><em>).</em> Yield 60%. Yellow powder, m.p. 250–251 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3421, 3011, 2921, 1628, 1589, 1443, 1303, 1143, 1068, 816, 774, 678, 609, 595. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.59 (s, 1H), 10.70 (d, <em>J</em> = 8.4 Hz, 1H), 10.07 (s, 1H), 9.46 (d, <em>J</em> = 8.4, 1H), 9.19 (d, <em>J</em> = 6.0 Hz, 1H), 8.43—8.37 (m, 2H), 8.21 (d, <em>J</em> = 9.0 Hz, 1H), 8.10 (d, <em>J</em> = 1.8 Hz, 1H), 7.73 (dd, <em>J</em> = 8.4, 6.6 Hz, 1H), 7.61—7.57 (m, 3H), 7.36 (d, <em>J</em> = 7.8 Hz, 2H), 6.04 (s, 2H), 2.80 (s, 3H), 2.66 (d, <em>J</em> = 1.2 Hz, 3H), 2.35 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.6, 143.8, 142.8, 142.7, 142.5, 142.0, 139.2, 136.7, 134.2, 131.0, 130.7, 130.7, 130.0, 129.9, 129.3, 129.2, 128.5, 128.4, 127.4, 127.0, 126. 7, 126.6, 122.8, 119.2, 118.8, 116.5, 115.4, 112.6, 63.6, 20.8, 19.9, 9.7 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>32</sub>H<sub>26</sub>N<sub>3</sub>O [M]<sup>+</sup> 468.2070, found 468.2071. HPLC purity: 95.6%.</p>
<p id="Par35"><em>4.2.2.14 1-(3,4-dichlorobenzyl)-3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)pyridin-1-ium bromide (</em><strong><em>a16</em></strong><em>).</em> Yield 79%. Yellow powder, m.p. 297–298 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3427, 3007, 1626, 1587, 1491, 1468, 1397, 1146, 817, 773, 707, 687. <sup><strong>1</strong></sup><strong>H NMR</strong> (400 MHz, DMSO-<em>d</em><sub>6</sub>) δ 10.62 (d, <em>J</em> = 8.4 Hz, 1H), 10.11 (s, 1H), 9.32 (d, <em>J</em> = 8.0 Hz, 1H), 9.22 (d, <em>J</em> = 6.0 Hz, 1H), 8.36 (dd, <em>J</em> = 8.0, 6.0 Hz, 1H), 8.28 (d, <em>J</em> = 9.2 Hz, 1H), 8.16 (d, <em>J</em> = 2.0 Hz, 1H), 8.11 (d, <em>J</em> = 9.2 Hz, 1H), 7.99 (d, <em>J</em> = 1.6 Hz, 1H), 7.85 (d, <em>J</em> = 8.4 Hz, 1H), 7.78 (dd, <em>J</em> = 8.4, 2.0 Hz, 1H), 7.72—7.67 (m, 1H), 7.51 (d, <em>J</em> = 6.8 Hz, 1H), 6.11 (s, 2H), 2.75 (s, 3H), 2.58 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (100 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.5, 143.7, 143.0, 142.3, 142.3, 141.9, 136.5, 134.7, 134.0, 132.5, 131.9, 131.7, 131.5, 130.7, 130.5, 129.9, 129.9, 128.4, 127.2, 126.7, 126.7, 126.6, 122.6, 119.1, 118.7, 116.4, 115.3, 112.4, 62.1, 19.9, 9.9 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>31</sub>H<sub>22</sub>N<sub>3</sub>OCl<sub>2</sub> [M]<sup>+</sup> 522.1134, found 522.1139. HPLC purity: 98.7%.</p>
<p id="Par36"><em>4.2.2.15 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(3-fluoro-4-nitrobenzyl) pyridin-1-ium bromide (</em><strong><em>a17</em></strong><em>).</em> Yield 61%. Yellow powder, m.p. 241–242 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3417, 3015, 2922, 1603, 1528, 1348, 1277, 1090, 841, 818, 746, 711, 677, 538. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.62 (s, 1H), 10.76 (d, <em>J</em> = 8.4 Hz, 1H), 10.18 (s, 1H), 9.53 (dt, <em>J</em> = 7.8, 1.8 Hz, 1H), 9.21 (d, <em>J</em> = 6.0 Hz, 1H), 8.46 (dd, <em>J</em> = 7.8, 6.0 Hz, 1H), 8.40 (d, <em>J</em> = 9.0 Hz, 1H), 8.32 (t, <em>J</em> = 8.4 Hz, 1H), 8.22 (d, <em>J</em> = 9.0 Hz, 1H), 8.11 (d, <em>J</em> = 1.2 Hz, 1H), 7.98 (dd, <em>J</em> = 12.0, 1.8 Hz, 1H), 7.76—7.71 (m, 2H), 7.58 (d, <em>J</em> = 7.2 Hz, 1H), 6.23 (s, 2H), 2.80 (s, 3H), 2.68 (d, <em>J</em> = 1.2 Hz, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 154.6 (d, <sup>1</sup><em>J</em><sub>C-F</sub> = 260.9 Hz), 149.6, 144.2, 143.8, 142.7, 142.6, 142.5 (d, <sup>3</sup><em>J</em><sub>C-F</sub> = 8.1 Hz), 137.2, 137.2, 136.8, 134.3, 131.9 (d, <sup>2</sup><em>J</em><sub>C-F</sub> = 54.7 Hz), 130.0, 128.7, 127.4, 127.1, 127.0, 126.7 (d, <sup>3</sup><em>J</em><sub>C-F</sub> = 9.0 Hz), 125.7 (d, <sup>4</sup><em>J</em><sub>C-F</sub> = 3.9 Hz), 122.8, 119.2, 119.1, 118.9 (d, <sup>2</sup><em>J</em><sub>C-F</sub> = 24.9 Hz), 116.5, 115.4, 112.6, 62.2, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>31</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub>F [M]<sup>+</sup> 517.1670, found 517.1670. HPLC purity: 96.3%.</p>
<p id="Par37"><em>4.2.2.16 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(3-methyl-4-nitrobenzyl) pyridin-1-ium bromide (</em><strong><em>a18</em></strong><em>).</em> Yield 47%. Yellow powder, m.p. 275–276 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3423, 3014, 2926, 1615, 1522, 1345, 1281, 1144, 967, 842, 820, 775, 679, 595. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.60 (s, 1H), 10.74 (d, <em>J</em> = 8.4 Hz, 1H), 10.16 (s, 1H), 9.51 (d, <em>J</em> = 8.4 Hz, 1H), 9.21 (d, <em>J</em> = 6.0 Hz, 1H), 8.44 (dd, <em>J</em> = 7.8, 6.0 Hz, 1H), 8.39 (d, <em>J</em> = 9.6 Hz, 1H), 8.21 (d, <em>J</em> = 9.0 Hz, 1H), 8.12 (d, <em>J</em> = 8.4 Hz, 1H), 8.10 (d, <em>J</em> = 1.2 Hz, 1H), 7.81 (d, <em>J</em> = 1.8 Hz, 1H), 7.76—7.71 (m, 2H), 7.57 (d, <em>J</em> = 6.6 Hz, 1H), 6.18 (s, 2H), 2.80 (s, 3H), 2.67 (d, <em>J</em> = 1.2 Hz, 3H), 2.55 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.6, 149.3, 144.1, 143.5, 142.6, 142.5, 142.3, 139.1, 136.6, 134.2, 133.5, 133.1, 131.0, 130.7, 130.0, 128.7, 127.8, 127.4, 127.0, 126.7, 126.6, 125.2, 122.8, 119.2, 118.8, 116.5, 115.4, 112.6, 62.7, 19.9, 19.4, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>32</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> [M]<sup>+</sup> 513.1921, found 513.1917. HPLC purity: 96.9%.</p>
<p id="Par38"><em>4.2.2.17 1-(2-bromo-4-nitrobenzyl)-3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl) pyridin-1-ium bromide (</em><strong><em>a19</em></strong><em>).</em> Yield 40%. Yellow powder, m.p. 266–267 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3423, 3037, 1623, 1587, 1523, 1346, 1146, 1024, 840, 816, 795, 678. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.58 (s, 1H), 10.69 (d, <em>J</em> = 9.0 Hz, 1H), 10.11 (s, 1H), 9.58 (d, <em>J</em> = 8.4 Hz, 1H), 9.19 (d, <em>J</em> = 6.0 Hz, 1H), 8.65 (d, <em>J</em> = 2.4 Hz, 1H), 8.50 (dd, <em>J</em> = 8.4, 6.0 Hz, 1H), 8.38 (d, <em>J</em> = 9.0 Hz, 1H), 8.34 (dd, <em>J</em> = 8.4, 2.4 Hz, 1H), 8.20 (d, <em>J</em> = 9.0 Hz, 1H), 8.09 (d, <em>J</em> = 1.8 Hz, 1H), 7.71 (dd, <em>J</em> = 8.4, 7.2 Hz, 1H), 7.61 (d, <em>J</em> = 9.0 Hz, 1H), 7.56 (d, <em>J</em> = 7.2 Hz, 1H), 6.32 (s, 2H). 2.79 (s, 3H), 2.66 (d, <em>J</em> = 1.2 Hz, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.7, 148.4, 144.5, 143.9, 142.6, 142.5, 142.4, 140.5, 136.7, 134.2, 131.2, 131.0, 130.7, 130.0, 128.7, 127.9, 127.4, 127.0, 126.7, 126.5, 123.4, 123.4, 122.8, 119.2, 118.8, 116.5, 115.4, 112.6, 63.3, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>31</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub>Br [M]<sup>+</sup>577.0870, found 577.0876. HPLC purity: 96.9%.</p>
<p id="Par39"><em>4.2.2.18 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(naphthalen-1-ylmethyl) pyridin-1-ium bromide (</em><strong><em>a20</em></strong><em>).</em> Yield 87%. Yellow powder, m.p. 266–267 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3428, 3192, 3064, 3008, 2931, 2861, 1868, 1626, 1491, 1452, 1398, 1173, 814, 796, 774, 677. <sup><strong>1</strong></sup><strong>H NMR</strong> (400 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.17 (s, 1H), 10.33 (d, <em>J</em> = 8.4 Hz, 1H), 9.85 (s, 1H), 9.23 (d, <em>J</em> = 8.0 Hz, 1H), 9.19 (d, <em>J</em> = 6.0 Hz, 1H), 8.35—8.25 (m, 2H), 8.17—8.10 (m, 2H), 8.06 (d, <em>J</em> = 8.0 Hz, 1H), 7.98 (d, <em>J</em> = 9.2 Hz, 1H), 7.84 (s, 1H), 7.71—7.66 (m, 3H), 7.64—7.54 (m, 2H), 7.42 (d, <em>J</em> = 7.2 Hz, 1H), 6.55 (s, 2H), 2.66 (s, 3H), 2.44 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (100 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.4, 143.7, 142.3, 142.2, 142.0, 141.6, 136.44, 134.0, 133.7, 130.6, 130.5, 130.5, 130.4, 129.8, 129.2, 129.2, 129.0, 128.4, 127.7, 127.2, 126.8, 126.7, 126.5, 126.4, 125.8, 123.1, 122.5, 118.9, 118.7, 116.3, 115.3, 112.3, 61.4, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>35</sub>H<sub>26</sub>N<sub>3</sub>O [M]<sup>+</sup> 504.2070, found 504.2074. HPLC purity: 98.0%.</p>
<p id="Par40"><em>4.2.2.19 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(naphthalen-2-ylmethyl) pyridin-1-ium bromide (</em><strong><em>a21</em></strong><em>).</em> Yield 65%. Yellow powder, m.p. 288–289 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3420, 3041, 3004, 2918, 1805, 1589, 1393, 1370, 1282, 1160, 851, 816, 773, 678. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.57 (s, 1H), 10.65 (d, <em>J</em> = 8.4 Hz, 1H), 10.13 (s, 1H), 9.48 (d, <em>J</em> = 8.4 Hz, 1H), 9.27 (d, <em>J</em> = 6.0 Hz, 1H), 8.45—8.40 (m, 1H), 8.37 (d, <em>J</em> = 9.0 Hz, 1H), 8.26 (s, 1H), 8.18 (d, <em>J</em> = 9.0 Hz, 1H), 8.12—8.06 (m, 2H), 8.04—8.00 (m, 2H), 7.79 (d, <em>J</em> = 8.4 Hz, 1H), 7.64—7.58 (m, 3H), 7.55 (d, <em>J</em> = 7.2 Hz, 1H), 6.27 (s, 2H), 2.78 (s, 3H), 2.65 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.6, 144.0, 143.0, 142.6, 142.5, 142.0, 136.7, 134.2, 133.1, 132.8, 131.4, 130.8, 130.6, 129.9, 129.2, 128.9, 128.5, 128.2, 127.8, 127.3, 127.2, 127.0, 126.9, 126.6, 126.5, 126.1, 122.8, 119.1, 118.8, 116.5, 115.4, 112.6, 63.9, 19.9, 9.8 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>35</sub>H<sub>26</sub>N<sub>3</sub>O [M]<sup>+</sup> 504.2070, found 504.2069. HPLC purity: 96.4%.</p>
<p id="Par41"><em>4.2.2.20 3-(1,6-dimethyl-12H-furo[2′,3′:1,2]phenanthro[3,4-d]imidazol-11-yl)-1-(2-methylallyl) pyridin-1-ium bromide (</em><strong><em>a22</em></strong><em>).</em> Yield 73%. Yellow powder, m.p. 290–291 °C. IR <em>ν</em><sub>max</sub> (cm<sup>−1</sup>): 3421, 2922, 1625, 1490, 1283, 1161, 1104, 1068, 815, 773, 680, 592. <sup><strong>1</strong></sup><strong>H NMR</strong> (600 MHz, DMSO-<em>d</em><sub>6</sub>) δ 13.48 (s, 1H), 10.68 (d, <em>J</em> = 8.4 Hz, 1H), 9.96 (s, 1H), 9.47 (d, <em>J</em> = 7.8 Hz, 1H), 9.09 (d, <em>J</em> = 6.0 Hz, 1H), 8.41 (t, <em>J</em> = 7.2 Hz, 1H), 8.34 (d, <em>J</em> = 9.0 Hz, 1H), 8.16 (d, <em>J</em> = 9.0 Hz, 1H), 8.05 (s, 1H), 7.71 (t, <em>J</em> = 7.8 Hz, 1H), 7.53 (d, <em>J</em> = 6.6 Hz, 1H), 5.47 (s, 2H), 5.26 (s, 1H), 5.00 (s, 1H), 2.77 (s, 3H), 2.63 (s, 3H), 1.86 (s, 3H) ppm (one resonance was not observed due to active N–H of imidazole); <sup><strong>13</strong></sup><strong>C NMR</strong> (150 MHz, DMSO-<em>d</em><sub>6</sub>) δ 149.6, 144.0, 142.9, 142.5, 142.4, 142.2, 139.6, 136.7, 134.2, 130.7, 130.6, 130.0, 128.4, 127.3, 126. 9, 126.7, 126.6, 122.7, 119.2, 118.8, 116.6, 116.4, 115.4, 112.6, 65.8, 19.9, 19.7, 9.9 ppm. <strong>HRMS</strong> (ESI-TOF) m/z Calcd for C<sub>28</sub>H<sub>24</sub>N<sub>3</sub>O [M]<sup>+</sup> 418.1914, found 418.1917.</p></section></section><section id="Sec16"><h3 class="pmc_sec_title">Biological</h3>
<section id="Sec17"><h4 class="pmc_sec_title">Materials and cell culture</h4>
<p id="Par42">The human cancer cell lines, including breast cancer (MDA-MB-231), hepatocellular carcinoma (HepG2), and prostate cancer (22RV1) were obtained from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China). Cells were cultured in medium supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin and 100 mg/mL streptomycin (HyClone, Logan, UT, USA). All the cells were incubated at 37 °C, 5% CO<sub>2</sub> in a humidified atmosphere.</p></section><section id="Sec18"><h4 class="pmc_sec_title">Cytotoxicity assay</h4>
<p id="Par43">Cytotoxic activities were evaluated by the MTS assay. All the compounds tested were absolutely dissolved to 10 mM in dimethyl sulfoxide (DMSO) in stock. Cells (5 × 10<sup>3</sup> cells/well) were plated into 96-well plates and cultured for 12 h before treatment and continuously exposed to 0.032, 0.16, 0.8, 4 and 20 µM test compounds for 48 h. Then MTS reagent (Promega, Madison, WI, USA) was added to each well, and cells were incubated at 37 °C for an additional 1–4 h and the optical density (OD) was measured at 492 nm using a microplate reader (Bio-Rad, Hercules, CA, USA). The IC<sub>50</sub> values were calculated from dose–response curves.</p></section><section id="Sec19"><h4 class="pmc_sec_title">Cell cycle analysis</h4>
<p id="Par44">For cell cycle analysis, cells were harvested and washed twice with phosphate-buffered saline (PBS), then fixed overnight at 4 °C in 70% ethanol. After fixation, cells were washed again and incubated with propidium iodide (PI, 50 µg/mL) in the presence of RNase A (50 µg/mL) at room temperature for 30 min. Cell cycle distribution was analyzed by flow cytometry using a FACSCalibur instrument (BD Biosciences, San Jose, CA, USA). Data analysis was performed using FlowJo software (version 10.9.0).</p></section><section id="Sec20"><h4 class="pmc_sec_title">Apoptosis analysis</h4>
<p id="Par45">Cell apoptosis was analyzed by flow cytometry using an Annexin V-FITC/PI apoptosis detection kit (BD Biosciences, Franklin Lakes, NJ, USA), according to the manufacturer's instructions. Briefly, cells were seeded into 6-well plates at 3 × 10<sup>5</sup> cells/well, and treated with indicated concentrations of test compounds for 48 h. Cells were harvested, washed twice with cold PBS, and resuspended in binding buffer containing Annexin V-FITC and PI. Following incubation at room temperature in the dark for 15 min, fluorescence intensity was quantified using a FACS Calibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA).</p></section><section id="Sec21"><h4 class="pmc_sec_title">Scratch wound healing assay</h4>
<p id="Par46">Cell migration rates following 24 h incubation with <strong>a4</strong> was quantitatively assessed using ImageJ software by measuring the wound closure area between the opposing edges.</p></section><section id="Sec22"><h4 class="pmc_sec_title">PI3K activity assay</h4>
<p id="Par47">The inhibitory activity of <strong>a4</strong> on PI3Kα was evaluated as previously based on the production of PIP3 with the PI3-Kinase Activity ELISA kit (K-1000 s, Echelon) [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>].</p></section><section id="Sec23"><h4 class="pmc_sec_title">Western blot analysis</h4>
<p id="Par48">The cells (Breast cancer, MDA-MB-231) were treated with compounds for indicated time and subjected to western blot analysis as previously [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. The antibodies against AKT (#4691), phosphor-AKT (Ser473) (#9271), S6K (#2708), phosphor-S6K (Thr389) (#9234), S6 (#9202), phospho-S6 (Ser240/244) (#88441) and PD-L1 (#13684) were all from the Cell signaling technology, and the antibody for GAPDH (MAB374) was provided by Sigma.</p></section><section id="Sec24"><h4 class="pmc_sec_title">Statistical analysis</h4>
<p id="Par49">All data were expressed as means ± standard deviation (SD). Statistical analyses were performed using GraphPad Prism 9.5 software. Pairwise comparisons among groups were analyzed using Tukey's test. Differences were considered statistically significant at <em>p</em> &lt; 0.05.</p></section></section></section><section id="Sec25"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12332164/bin/13659_2025_534_MOESM1_ESM.doc" data-ga-action="click_feat_suppl" class="usa-link">Supplementary material 1.</a><sup> (9.8MB, doc) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The study was funded by the National Natural Science Foundation of China (No. 32260159, 82360725), the Yunnan Fundamental Research Projects (202301AS070022), the Major Science and Technology Special Projects of Yunnan Province (202402AA310025), the Yunnan Young &amp; Elite Talents Project (YNWR-QNBJ-2020-084), Yunnan University Student Innovation and Entrepreneurship Training Program (S202310673202).</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>HZ and YW contributed equally to this work. YF conceived and designed the experiments chemistry experiments. LK and YL conceived and designed the pharmacological experiments; HZ, YW, ZL, LL, JX, XY and ZZ performed the experiments; HZ, YW, ZL and JX analyzed the data; and HZ, YF and LK wrote the article.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>National Natural Science Foundation of China, 32260159, Yan Li, 82360725, Lingmei Kong, Applied Basic Research Foundation of Yunnan Province, 202301AS070022, Yan Li, Major Science and Technology Projects in Yunnan Province, 202402AA310025, Yan Li, Yunan Ten Thousand Talents Plan Young and Elite Talents Project, YNWR-QNBJ-2020-084, Lingmei Kong</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>All relevant data are within the manuscript.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par50">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Huimin Zhao and Yuyang Wang have contributed equally to this work.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Yongsheng Fang, Email: ysfang@ucas.ac.cn.</p>
<p>Lingmei Kong, Email: konglingmei@ynu.edu.cn.</p>
<p>Yan Li, Email: yan.li@ynu.edu.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
</cite> [<a href="https://doi.org/10.3322/caac.21834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bray%20F,%20Laversanne%20M,%20Sung%20H,%20Ferlay%20J,%20Siegel%20RL,%20Soerjomataram%20I,%20et%20al.%20Global%20cancer%20statistics%202022:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries.%20CA%20Cancer%20J%20Clin.%202024;74(3):229%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Bergholz JS, Wang Q, Kabraji S, Zhao JJ. Integrating immunotherapy and targeted therapy in cancer treatment: mechanistic insights and clinical implications. Clin Cancer Res. 2020;26(21):5557–66.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-19-2300" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7641965/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32576627/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bergholz%20JS,%20Wang%20Q,%20Kabraji%20S,%20Zhao%20JJ.%20Integrating%20immunotherapy%20and%20targeted%20therapy%20in%20cancer%20treatment:%20mechanistic%20insights%20and%20clinical%20implications.%20Clin%20Cancer%20Res.%202020;26(21):5557%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Boshuizen J, Peeper DS. Rational cancer treatment combinations: an urgent clinical need. Mol Cell. 2020;78(6):1002–18.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2020.05.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32559422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Boshuizen%20J,%20Peeper%20DS.%20Rational%20cancer%20treatment%20combinations:%20an%20urgent%20clinical%20need.%20Mol%20Cell.%202020;78(6):1002%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. STTT. 2021;6(1):201.</cite> [<a href="https://doi.org/10.1038/s41392-021-00572-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8165101/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34054126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhong%20L,%20Li%20Y,%20Xiong%20L,%20Wang%20W,%20Wu%20M,%20Yuan%20T,%20et%20al.%20Small%20molecules%20in%20targeted%20cancer%20therapy:%20advances,%20challenges,%20and%20future%20perspectives.%20STTT.%202021;6(1):201." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Luo Z, Yin F, Wang X, Kong L. Progress in approved drugs from natural product resources. Chin J Nat Med. 2024;22(3):195–211.
</cite> [<a href="https://doi.org/10.1016/S1875-5364(24)60582-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38553188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo%20Z,%20Yin%20F,%20Wang%20X,%20Kong%20L.%20Progress%20in%20approved%20drugs%20from%20natural%20product%20resources.%20Chin%20J%20Nat%20Med.%202024;22(3):195%E2%80%93211." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770–803.
</cite> [<a href="https://doi.org/10.1021/acs.jnatprod.9b01285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32162523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Newman%20DJ,%20Cragg%20GM.%20Natural%20products%20as%20sources%20of%20new%20drugs%20over%20the%20nearly%20four%20decades%20from%2001/1981%20to%2009/2019.%20J%20Nat%20Prod.%202020;83(3):770%E2%80%93803." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Tian XH, Wu JH. Tanshinone derivatives: a patent review (January 2006 - September 2012). Expert Opin Ther Pat. 2013;23(1):19–29.
</cite> [<a href="https://doi.org/10.1517/13543776.2013.736494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23094864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20XH,%20Wu%20JH.%20Tanshinone%20derivatives:%20a%20patent%20review%20(January%202006%20-%20September%202012).%20Expert%20Opin%20Ther%20Pat.%202013;23(1):19%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Dong Y, Morris-Natschke SL, Lee KH. Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents. Nat Prod Rep. 2011;28(3):529–42.
</cite> [<a href="https://doi.org/10.1039/c0np00035c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21225077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dong%20Y,%20Morris-Natschke%20SL,%20Lee%20KH.%20Biosynthesis,%20total%20syntheses,%20and%20antitumor%20activity%20of%20tanshinones%20and%20their%20analogs%20as%20potential%20therapeutic%20agents.%20Nat%20Prod%20Rep.%202011;28(3):529%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Gao H, Liu X, Sun W, Kang N, Liu Y, Yang S, et al. Total tanshinones exhibits anti-inflammatory effects through blocking TLR4 dimerization via the MyD88 pathway. Cell Death Dis. 2017;8(8): e3004.
</cite> [<a href="https://doi.org/10.1038/cddis.2017.389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5596575/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28817116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20H,%20Liu%20X,%20Sun%20W,%20Kang%20N,%20Liu%20Y,%20Yang%20S,%20et%20al.%20Total%20tanshinones%20exhibits%20anti-inflammatory%20effects%20through%20blocking%20TLR4%20dimerization%20via%20the%20MyD88%20pathway.%20Cell%20Death%20Dis.%202017;8(8):%20e3004." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Shi M, Luo X, Ju G, Li L, Huang S, Zhang T, et al. Enhanced diterpene tanshinone accumulation and bioactivity of transgenic <em>Salvia miltiorrhiza</em> hairy roots by pathway engineering. J Agric Food Chem. 2016;64(12):2523–30.
</cite> [<a href="https://doi.org/10.1021/acs.jafc.5b04697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26753746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20M,%20Luo%20X,%20Ju%20G,%20Li%20L,%20Huang%20S,%20Zhang%20T,%20et%20al.%20Enhanced%20diterpene%20tanshinone%20accumulation%20and%20bioactivity%20of%20transgenic%20Salvia%20miltiorrhiza%20hairy%20roots%20by%20pathway%20engineering.%20J%20Agric%20Food%20Chem.%202016;64(12):2523%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Zhou W, Huang Q, Wu X, Zhou Z, Ding M, Shi M, et al. Comprehensive transcriptome profiling of <em>Salvia miltiorrhiza</em> for discovery of genes associated with the biosynthesis of tanshinones and phenolic acids. Sci Rep. 2017;7(1):10554.
</cite> [<a href="https://doi.org/10.1038/s41598-017-10215-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5585387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28874707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20W,%20Huang%20Q,%20Wu%20X,%20Zhou%20Z,%20Ding%20M,%20Shi%20M,%20et%20al.%20Comprehensive%20transcriptome%20profiling%20of%20Salvia%20miltiorrhiza%20for%20discovery%20of%20genes%20associated%20with%20the%20biosynthesis%20of%20tanshinones%20and%20phenolic%20acids.%20Sci%20Rep.%202017;7(1):10554." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Wu Q, Zheng K, Huang X, Li L, Mei W. Tanshinone-IIA-based analogues of imidazole alkaloid act as potent inhibitors to block breast cancer invasion and metastasis in vivo. J Med Chem. 2018;61(23):10488–501.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.8b01018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30398868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20Q,%20Zheng%20K,%20Huang%20X,%20Li%20L,%20Mei%20W.%20Tanshinone-IIA-based%20analogues%20of%20imidazole%20alkaloid%20act%20as%20potent%20inhibitors%20to%20block%20breast%20cancer%20invasion%20and%20metastasis%20in%20vivo.%20J%20Med%20Chem.%202018;61(23):10488%E2%80%93501." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Xue Z, Li CY, Zhu GH, Song LL, Zhao YW, Ma YH, et al. Discovery of tetrahydro tanshinone I as a naturally occurring covalent pan-inhibitor against gut microbial bile salt hydrolases. J Agric Food Chem. 2024;72(42):23233–45.
</cite> [<a href="https://doi.org/10.1021/acs.jafc.4c03617" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39378230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xue%20Z,%20Li%20CY,%20Zhu%20GH,%20Song%20LL,%20Zhao%20YW,%20Ma%20YH,%20et%20al.%20Discovery%20of%20tetrahydro%20tanshinone%20I%20as%20a%20naturally%20occurring%20covalent%20pan-inhibitor%20against%20gut%20microbial%20bile%20salt%20hydrolases.%20J%20Agric%20Food%20Chem.%202024;72(42):23233%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Zhu W, Bao X, Yang Y, Xing M, Xiong S, Chen S, et al. Peripheral evolution of tanshinone IIA and cryptotanshinone for discovery of a potent and specific NLRP3 inflammasome inhibitor. J Med Chem. 2025;68(3):3460–79.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c02648" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39847657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20W,%20Bao%20X,%20Yang%20Y,%20Xing%20M,%20Xiong%20S,%20Chen%20S,%20et%20al.%20Peripheral%20evolution%20of%20tanshinone%20IIA%20and%20cryptotanshinone%20for%20discovery%20of%20a%20potent%20and%20specific%20NLRP3%20inflammasome%20inhibitor.%20J%20Med%20Chem.%202025;68(3):3460%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ding C, Tian Q, Li J, Jiao M, Song S, Wang Y, et al. Structural modification of natural product Tanshinone I leading to discovery of novel nitrogen-enriched derivatives with enhanced anticancer profile and improved drug-like properties. J Med Chem. 2018;61(3):760–76.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.7b01259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29294282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding%20C,%20Tian%20Q,%20Li%20J,%20Jiao%20M,%20Song%20S,%20Wang%20Y,%20et%20al.%20Structural%20modification%20of%20natural%20product%20Tanshinone%20I%20leading%20to%20discovery%20of%20novel%20nitrogen-enriched%20derivatives%20with%20enhanced%20anticancer%20profile%20and%20improved%20drug-like%20properties.%20J%20Med%20Chem.%202018;61(3):760%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Wang W, Li J, Ding Z, Li Y, Wang J, Chen S, et al. Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway. J Cell Mol Med. 2019;23(9):6454–65.
</cite> [<a href="https://doi.org/10.1111/jcmm.14539" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6714145/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31293090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20W,%20Li%20J,%20Ding%20Z,%20Li%20Y,%20Wang%20J,%20Chen%20S,%20et%20al.%20Tanshinone%20I%20inhibits%20the%20growth%20and%20metastasis%20of%20osteosarcoma%20via%20suppressing%20JAK/STAT3%20signalling%20pathway.%20J%20Cell%20Mol%20Med.%202019;23(9):6454%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Zhou J, Jiang YY, Chen H, Wu YC, Zhang L. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Cell Prolif. 2020;53(2): e12739.
</cite> [<a href="https://doi.org/10.1111/cpr.12739" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7046305/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31820522/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20J,%20Jiang%20YY,%20Chen%20H,%20Wu%20YC,%20Zhang%20L.%20Tanshinone%20I%20attenuates%20the%20malignant%20biological%20properties%20of%20ovarian%20cancer%20by%20inducing%20apoptosis%20and%20autophagy%20via%20the%20inactivation%20of%20PI3K/AKT/mTOR%20pathway.%20Cell%20Prolif.%202020;53(2):%20e12739." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="/articles/PMC11839184/" class="text-red">Retracted</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Huang X, Jin L, Deng H, Wu D, Shen QK, Quan ZS, et al. Research and development of natural product tanshinone I: pharmacology, total synthesis, and structure modifications. Front Pharmacol. 2022;13:920411.
</cite> [<a href="https://doi.org/10.3389/fphar.2022.920411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9315943/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35903340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20X,%20Jin%20L,%20Deng%20H,%20Wu%20D,%20Shen%20QK,%20Quan%20ZS,%20et%20al.%20Research%20and%20development%20of%20natural%20product%20tanshinone%20I:%20pharmacology,%20total%20synthesis,%20and%20structure%20modifications.%20Front%20Pharmacol.%202022;13:920411." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Liu Y, Li X, Li Y, Wang L, Xue M. Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic-mass spectrometry and the application to pharmacokinetics in rats. J Pharm Biomed Anal. 2010;53(3):698–704.
</cite> [<a href="https://doi.org/10.1016/j.jpba.2010.03.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20430561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Li%20X,%20Li%20Y,%20Wang%20L,%20Xue%20M.%20Simultaneous%20determination%20of%20danshensu,%20rosmarinic%20acid,%20cryptotanshinone,%20tanshinone%20IIA,%20tanshinone%20I%20and%20dihydrotanshinone%20I%20by%20liquid%20chromatographic-mass%20spectrometry%20and%20the%20application%20to%20pharmacokinetics%20in%20rats.%20J%20Pharm%20Biomed%20Anal.%202010;53(3):698%E2%80%93704." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Park EJ, Ji HY, Kim NJ, Song WY, Kim YH, Kim YC, et al. Simultaneous determination of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study of a standardized fraction of <em>Salvia miltiorrhiza</em>, PF2401-SF. Biomed Chromatogr. 2008;22(5):548–55.
</cite> [<a href="https://doi.org/10.1002/bmc.968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18205136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Park%20EJ,%20Ji%20HY,%20Kim%20NJ,%20Song%20WY,%20Kim%20YH,%20Kim%20YC,%20et%20al.%20Simultaneous%20determination%20of%20tanshinone%20I,%20dihydrotanshinone%20I,%20tanshinone%20IIA%20and%20cryptotanshinone%20in%20rat%20plasma%20by%20liquid%20chromatography-tandem%20mass%20spectrometry:%20application%20to%20a%20pharmacokinetic%20study%20of%20a%20standardized%20fraction%20of%20Salvia%20miltiorrhiza,%20PF2401-SF.%20Biomed%20Chromatogr.%202008;22(5):548%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Yu H, Subedi RK, Nepal PR, Kim YG, Choi HK. Enhancement of solubility and dissolution rate of cryptotanshinone, tanshinone I and tanshinone IIA extracted from <em>Salvia miltiorrhiza</em>. Arch Pharm Res. 2012;35(8):1457–64.
</cite> [<a href="https://doi.org/10.1007/s12272-012-0816-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22941489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20H,%20Subedi%20RK,%20Nepal%20PR,%20Kim%20YG,%20Choi%20HK.%20Enhancement%20of%20solubility%20and%20dissolution%20rate%20of%20cryptotanshinone,%20tanshinone%20I%20and%20tanshinone%20IIA%20extracted%20from%20Salvia%20miltiorrhiza.%20Arch%20Pharm%20Res.%202012;35(8):1457%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Deng G, Zhou B, Wang J, Chen Z, Gong L, Gong Y, et al. Synthesis and antitumor activity of novel steroidal imidazolium salt derivatives. Eur J Med Chem. 2019;168:232–52.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.02.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30822712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng%20G,%20Zhou%20B,%20Wang%20J,%20Chen%20Z,%20Gong%20L,%20Gong%20Y,%20et%20al.%20Synthesis%20and%20antitumor%20activity%20of%20novel%20steroidal%20imidazolium%20salt%20derivatives.%20Eur%20J%20Med%20Chem.%202019;168:232%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Liu Z, Zhang Y, Dong J, Fang Y, Jiang Y, Yang X, et al. Synthesis and antitumor activity of novel hybrid compounds between 1,4-benzodioxane and imidazolium salts. Arch Pharm. 2022;355(10): e2200109.</cite> [<a href="https://doi.org/10.1002/ardp.202200109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35674481/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Z,%20Zhang%20Y,%20Dong%20J,%20Fang%20Y,%20Jiang%20Y,%20Yang%20X,%20et%20al.%20Synthesis%20and%20antitumor%20activity%20of%20novel%20hybrid%20compounds%20between%201,4-benzodioxane%20and%20imidazolium%20salts.%20Arch%20Pharm.%202022;355(10):%20e2200109." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Yin M, Fang Y, Sun X, Xue M, Zhang C, Zhu Z, et al. Synthesis and anticancer activity of podophyllotoxin derivatives with nitrogen-containing heterocycles. Front Chem. 2023;11:1191498.
</cite> [<a href="https://doi.org/10.3389/fchem.2023.1191498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10206303/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37234201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20M,%20Fang%20Y,%20Sun%20X,%20Xue%20M,%20Zhang%20C,%20Zhu%20Z,%20et%20al.%20Synthesis%20and%20anticancer%20activity%20of%20podophyllotoxin%20derivatives%20with%20nitrogen-containing%20heterocycles.%20Front%20Chem.%202023;11:1191498." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Zhou H, Yu C, Kong L, Xu X, Yan J, Li Y, et al. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells. Oncogene. 2019;38(18):3371–86.
</cite> [<a href="https://doi.org/10.1038/s41388-018-0674-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6756013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30635656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20H,%20Yu%20C,%20Kong%20L,%20Xu%20X,%20Yan%20J,%20Li%20Y,%20et%20al.%20B591,%20a%20novel%20specific%20pan-PI3K%20inhibitor,%20preferentially%20targets%20cancer%20stem%20cells.%20Oncogene.%202019;38(18):3371%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Dwivedi AR, Jaiswal S, Kukkar D, Kumar R, Singh TG, Singh MP, et al. A decade of pyridine-containing heterocycles in US FDA approved drugs: a medicinal chemistry-based analysis. RSC Med Chem. 2024;16(1):12–36.
</cite> [<a href="https://doi.org/10.1039/d4md00632a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11528346/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39493227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dwivedi%20AR,%20Jaiswal%20S,%20Kukkar%20D,%20Kumar%20R,%20Singh%20TG,%20Singh%20MP,%20et%20al.%20A%20decade%20of%20pyridine-containing%20heterocycles%20in%20US%20FDA%20approved%20drugs:%20a%20medicinal%20chemistry-based%20analysis.%20RSC%20Med%20Chem.%202024;16(1):12%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Vitaku E, Smith DT, Njardarson JT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J Med Chem. 2014;57(24):10257–74.
</cite> [<a href="https://doi.org/10.1021/jm501100b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25255204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vitaku%20E,%20Smith%20DT,%20Njardarson%20JT.%20Analysis%20of%20the%20structural%20diversity,%20substitution%20patterns,%20and%20frequency%20of%20nitrogen%20heterocycles%20among%20U.S.%20FDA%20approved%20pharmaceuticals.%20J%20Med%20Chem.%202014;57(24):10257%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Albratty M, Alhazmi HA. Novel pyridine and pyrimidine derivatives as promising anticancer agents: a review. Arab J Chem. 2022;15(6):103846.</cite> [<a href="https://scholar.google.com/scholar_lookup?Albratty%20M,%20Alhazmi%20HA.%20Novel%20pyridine%20and%20pyrimidine%20derivatives%20as%20promising%20anticancer%20agents:%20a%20review.%20Arab%20J%20Chem.%202022;15(6):103846." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Xu T, Xue Z, Li X, Zhang M, Yang R, Qin S, et al. Development of membrane-targeting osthole derivatives containing pyridinium quaternary ammonium moieties with potent anti-methicillin-resistant <em>Staphylococcus aureus</em> properties. J Med Chem. 2025;68(7):7459–75.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c03167" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40205941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20T,%20Xue%20Z,%20Li%20X,%20Zhang%20M,%20Yang%20R,%20Qin%20S,%20et%20al.%20Development%20of%20membrane-targeting%20osthole%20derivatives%20containing%20pyridinium%20quaternary%20ammonium%20moieties%20with%20potent%20anti-methicillin-resistant%20Staphylococcus%20aureus%20properties.%20J%20Med%20Chem.%202025;68(7):7459%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Mishra T, Gupta S, Rai P, Khandelwal N, Chourasiya M, Kushwaha V, et al. Anti-adipogenic action of a novel oxazole derivative through activation of AMPK pathway. Eur J Med Chem. 2023;262:115895.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2023.115895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37883898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mishra%20T,%20Gupta%20S,%20Rai%20P,%20Khandelwal%20N,%20Chourasiya%20M,%20Kushwaha%20V,%20et%20al.%20Anti-adipogenic%20action%20of%20a%20novel%20oxazole%20derivative%20through%20activation%20of%20AMPK%20pathway.%20Eur%20J%20Med%20Chem.%202023;262:115895." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Varma MV, Kaushal AM, Garg S. Rapid and selective UV spectrophotometric and RP-HPLC methods for dissolution studies of oxybutynin immediate-release and controlled-release formulations. J Pharm Biomed Anal. 2004;36(3):669–74.
</cite> [<a href="https://doi.org/10.1016/j.jpba.2004.07.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15522548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Varma%20MV,%20Kaushal%20AM,%20Garg%20S.%20Rapid%20and%20selective%20UV%20spectrophotometric%20and%20RP-HPLC%20methods%20for%20dissolution%20studies%20of%20oxybutynin%20immediate-release%20and%20controlled-release%20formulations.%20J%20Pharm%20Biomed%20Anal.%202004;36(3):669%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K Pathway in human disease. Cell. 2017;170(4):605–35.
</cite> [<a href="https://doi.org/10.1016/j.cell.2017.07.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5726441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28802037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fruman%20DA,%20Chiu%20H,%20Hopkins%20BD,%20Bagrodia%20S,%20Cantley%20LC,%20Abraham%20RT.%20The%20PI3K%20Pathway%20in%20human%20disease.%20Cell.%202017;170(4):605%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7(8):606–19.
</cite> [<a href="https://doi.org/10.1038/nrg1879" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16847462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Engelman%20JA,%20Luo%20J,%20Cantley%20LC.%20The%20evolution%20of%20phosphatidylinositol%203-kinases%20as%20regulators%20of%20growth%20and%20metabolism.%20Nat%20Rev%20Genet.%202006;7(8):606%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Quan Z, Yang Y, Zheng H, Zhan Y, Luo J, Ning Y, et al. Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer. J Cancer. 2022;13(13):3434–43.
</cite> [<a href="https://doi.org/10.7150/jca.77619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9608206/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36313041/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Quan%20Z,%20Yang%20Y,%20Zheng%20H,%20Zhan%20Y,%20Luo%20J,%20Ning%20Y,%20et%20al.%20Clinical%20implications%20of%20the%20interaction%20between%20PD-1/PD-L1%20and%20PI3K/AKT/mTOR%20pathway%20in%20progression%20and%20treatment%20of%20non-small%20cell%20lung%20cancer.%20J%20Cancer.%202022;13(13):3434%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Jia WQ, Luo SY, Guo H, Kong D. Development of PI3Kα inhibitors for tumor therapy. J Biomol Struct Dyn. 2023;41(17):8587–604.
</cite> [<a href="https://doi.org/10.1080/07391102.2022.2132293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36221910/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jia%20WQ,%20Luo%20SY,%20Guo%20H,%20Kong%20D.%20Development%20of%20PI3K%CE%B1%20inhibitors%20for%20tumor%20therapy.%20J%20Biomol%20Struct%20Dyn.%202023;41(17):8587%E2%80%93604." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12332164/bin/13659_2025_534_MOESM1_ESM.doc" data-ga-action="click_feat_suppl" class="usa-link">Supplementary material 1.</a><sup> (9.8MB, doc) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All relevant data are within the manuscript.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Natural Products and Bioprospecting are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s13659-025-00534-7"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13659_2025_Article_534.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12332164/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12332164/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332164%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332164/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12332164/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12332164/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40775593/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12332164/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40775593/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12332164/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12332164/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="sBaKRAgeSKAxeyw52F0Q59VURqzQx2gVvO7FRCwnTezrlLdNozFR2fklutdkpPWe">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
